Gene Symbol | Gene ID | Gene Info |
---|---|---|
Zbtb18
|
ENSMUSG00000063659.6 | Zbtb18 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
Zbtb18 | chr1_177449667_177450314 | 4169 | 0.177174 | -0.65 | 2.5e-08 | Click! |
Zbtb18 | chr1_177448882_177449429 | 3334 | 0.193768 | -0.58 | 9.5e-07 | Click! |
Zbtb18 | chr1_177450773_177451533 | 5332 | 0.164667 | -0.56 | 3.8e-06 | Click! |
Zbtb18 | chr1_177444257_177446079 | 230 | 0.898476 | -0.49 | 6.0e-05 | Click! |
Zbtb18 | chr1_177446374_177448525 | 1628 | 0.311892 | -0.47 | 1.3e-04 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr4_119356292_119356734 | 13.47 |
Ccdc30 |
coiled-coil domain containing 30 |
3289 |
0.15 |
chr7_107567353_107568299 | 12.35 |
Olfml1 |
olfactomedin-like 1 |
60 |
0.97 |
chrX_143825863_143827628 | 12.07 |
Capn6 |
calpain 6 |
587 |
0.46 |
chr5_75148315_75152589 | 11.98 |
Pdgfra |
platelet derived growth factor receptor, alpha polypeptide |
1840 |
0.2 |
chr2_62572999_62574382 | 10.11 |
Fap |
fibroblast activation protein |
130 |
0.97 |
chr3_49753928_49755610 | 9.32 |
Pcdh18 |
protocadherin 18 |
695 |
0.72 |
chr6_135362982_135365483 | 9.29 |
Emp1 |
epithelial membrane protein 1 |
1164 |
0.42 |
chr1_22268705_22269143 | 9.17 |
Gm28239 |
predicted gene 28239 |
31075 |
0.21 |
chr8_92827121_92828679 | 9.13 |
Mmp2 |
matrix metallopeptidase 2 |
609 |
0.71 |
chr14_110754045_110754474 | 9.11 |
Slitrk6 |
SLIT and NTRK-like family, member 6 |
890 |
0.57 |
chr15_27786588_27788615 | 8.78 |
Trio |
triple functional domain (PTPRF interacting) |
1037 |
0.6 |
chr5_75152837_75154692 | 8.43 |
Gm42802 |
predicted gene 42802 |
111 |
0.58 |
chr4_141242265_141243901 | 8.31 |
Arhgef19 |
Rho guanine nucleotide exchange factor (GEF) 19 |
190 |
0.9 |
chr4_126150157_126151254 | 8.04 |
Eva1b |
eva-1 homolog B (C. elegans) |
2173 |
0.18 |
chr12_33960516_33961726 | 7.98 |
Twist1 |
twist basic helix-loop-helix transcription factor 1 |
3450 |
0.27 |
chr5_21543417_21545108 | 7.89 |
Lrrc17 |
leucine rich repeat containing 17 |
699 |
0.68 |
chr5_113649742_113650879 | 7.51 |
Cmklr1 |
chemokine-like receptor 1 |
86 |
0.96 |
chr6_37440238_37440988 | 7.36 |
Creb3l2 |
cAMP responsive element binding protein 3-like 2 |
1533 |
0.51 |
chr14_62144401_62145177 | 7.33 |
Gm35419 |
predicted gene, 35419 |
26337 |
0.2 |
chr17_34041002_34041863 | 7.32 |
Col11a2 |
collagen, type XI, alpha 2 |
1777 |
0.1 |
chr7_6694119_6695702 | 7.13 |
Zim1 |
zinc finger, imprinted 1 |
1519 |
0.27 |
chr2_50943168_50943631 | 7.07 |
Gm13498 |
predicted gene 13498 |
33715 |
0.23 |
chrX_52609355_52610313 | 7.00 |
Gpc3 |
glypican 3 |
4087 |
0.23 |
chr12_73040722_73041603 | 6.93 |
Six1 |
sine oculis-related homeobox 1 |
1653 |
0.39 |
chr1_74090075_74091356 | 6.80 |
Tns1 |
tensin 1 |
636 |
0.71 |
chr8_25343082_25343881 | 6.75 |
5430421F17Rik |
RIKEN cDNA 5430421F17 gene |
37211 |
0.12 |
chr1_59269830_59270584 | 6.65 |
Cdk15 |
cyclin-dependent kinase 15 |
13079 |
0.18 |
chr9_60139459_60140875 | 6.59 |
Thsd4 |
thrombospondin, type I, domain containing 4 |
1053 |
0.62 |
chr8_13916565_13916787 | 6.53 |
Fbxo25 |
F-box protein 25 |
8873 |
0.12 |
chr1_163308490_163310681 | 6.40 |
Gm37644 |
predicted gene, 37644 |
518 |
0.77 |
chr5_119834833_119836185 | 6.32 |
Tbx5 |
T-box 5 |
646 |
0.68 |
chr4_130045795_130046417 | 6.31 |
Gm12963 |
predicted gene 12963 |
1668 |
0.25 |
chr13_51410301_51411730 | 6.24 |
S1pr3 |
sphingosine-1-phosphate receptor 3 |
2376 |
0.29 |
chr13_55827549_55829422 | 6.19 |
Gm47071 |
predicted gene, 47071 |
2235 |
0.21 |
chr13_51412096_51412399 | 6.02 |
S1pr3 |
sphingosine-1-phosphate receptor 3 |
3608 |
0.23 |
chr5_30913519_30915234 | 6.01 |
Emilin1 |
elastin microfibril interfacer 1 |
637 |
0.48 |
chr9_107982030_107984233 | 5.95 |
Gm20661 |
predicted gene 20661 |
38 |
0.54 |
chr13_63273798_63275383 | 5.68 |
Gm47585 |
predicted gene, 47585 |
990 |
0.28 |
chr2_155047589_155048127 | 5.54 |
a |
nonagouti |
243 |
0.9 |
chr1_162219788_162220533 | 5.47 |
Dnm3os |
dynamin 3, opposite strand |
292 |
0.87 |
chr9_20971771_20972108 | 5.44 |
S1pr2 |
sphingosine-1-phosphate receptor 2 |
2039 |
0.16 |
chr17_14692721_14694441 | 5.42 |
Thbs2 |
thrombospondin 2 |
654 |
0.74 |
chr5_13125231_13126281 | 5.40 |
Sema3a |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A |
163 |
0.95 |
chr8_115249806_115250627 | 5.38 |
Gm22556 |
predicted gene, 22556 |
197303 |
0.03 |
chr8_107545084_107547731 | 5.32 |
Wwp2 |
WW domain containing E3 ubiquitin protein ligase 2 |
1395 |
0.4 |
chrX_145348234_145349159 | 5.29 |
Lhfpl1 |
lipoma HMGIC fusion partner-like 1 |
254 |
0.95 |
chr4_139091031_139091422 | 5.17 |
Nbl1 |
NBL1, DAN family BMP antagonist |
880 |
0.49 |
chr16_14708078_14708290 | 5.12 |
Snai2 |
snail family zinc finger 2 |
2332 |
0.37 |
chr6_4483924_4484443 | 5.06 |
Gm37883 |
predicted gene, 37883 |
15 |
0.97 |
chr6_52236849_52237345 | 5.05 |
Hoxa10 |
homeobox A10 |
2158 |
0.09 |
chr17_75177945_75179637 | 5.01 |
Ltbp1 |
latent transforming growth factor beta binding protein 1 |
19 |
0.98 |
chr11_85667588_85668438 | 4.98 |
Bcas3 |
breast carcinoma amplified sequence 3 |
27309 |
0.17 |
chr8_95369090_95370386 | 4.97 |
Mmp15 |
matrix metallopeptidase 15 |
133 |
0.94 |
chr9_21495923_21496771 | 4.95 |
Mir199a-1 |
microRNA 199a-1 |
217 |
0.87 |
chr14_55782680_55784401 | 4.93 |
Adcy4 |
adenylate cyclase 4 |
146 |
0.88 |
chr7_105777795_105779093 | 4.92 |
Dchs1 |
dachsous cadherin related 1 |
9108 |
0.09 |
chr15_76458854_76459005 | 4.87 |
Scx |
scleraxis |
1409 |
0.2 |
chr11_99045898_99046473 | 4.86 |
Igfbp4 |
insulin-like growth factor binding protein 4 |
1126 |
0.37 |
chr5_113796469_113797793 | 4.81 |
Tmem119 |
transmembrane protein 119 |
3315 |
0.13 |
chr6_54591608_54592427 | 4.80 |
Fkbp14 |
FK506 binding protein 14 |
1131 |
0.44 |
chr6_101374596_101375205 | 4.79 |
Pdzrn3 |
PDZ domain containing RING finger 3 |
2442 |
0.26 |
chr2_32317910_32318744 | 4.79 |
Gm23363 |
predicted gene, 23363 |
62 |
0.57 |
chr8_77722901_77723292 | 4.76 |
4933431K23Rik |
RIKEN cDNA 4933431K23 gene |
488 |
0.72 |
chr11_118427861_118428375 | 4.76 |
C1qtnf1 |
C1q and tumor necrosis factor related protein 1 |
85 |
0.96 |
chr11_99047037_99047853 | 4.74 |
Igfbp4 |
insulin-like growth factor binding protein 4 |
134 |
0.94 |
chr8_36951282_36952693 | 4.73 |
Dlc1 |
deleted in liver cancer 1 |
370 |
0.88 |
chr10_82689904_82691051 | 4.73 |
Glt8d2 |
glycosyltransferase 8 domain containing 2 |
140 |
0.94 |
chr6_21985465_21987128 | 4.72 |
Cped1 |
cadherin-like and PC-esterase domain containing 1 |
300 |
0.93 |
chr13_118716404_118716600 | 4.71 |
Gm16263 |
predicted gene 16263 |
1106 |
0.45 |
chr2_27887830_27888871 | 4.70 |
2810430I11Rik |
RIKEN cDNA 2810430I11 gene |
1298 |
0.42 |
chr1_78817332_78818790 | 4.61 |
Kcne4 |
potassium voltage-gated channel, Isk-related subfamily, gene 4 |
1134 |
0.48 |
chr18_60646910_60648302 | 4.54 |
Synpo |
synaptopodin |
666 |
0.69 |
chr8_77721915_77722639 | 4.53 |
4933431K23Rik |
RIKEN cDNA 4933431K23 gene |
1307 |
0.39 |
chr2_65818279_65818945 | 4.52 |
Csrnp3 |
cysteine-serine-rich nuclear protein 3 |
27155 |
0.18 |
chr12_73049938_73051556 | 4.50 |
Six1 |
sine oculis-related homeobox 1 |
3140 |
0.26 |
chr1_38766937_38768045 | 4.49 |
2610300A13Rik |
RIKEN cDNA 2610300A13 gene |
307 |
0.91 |
chr13_118715747_118716385 | 4.48 |
Gm16263 |
predicted gene 16263 |
670 |
0.62 |
chr10_56468695_56469687 | 4.46 |
Gm9118 |
predicted gene 9118 |
28150 |
0.16 |
chr12_37112316_37112553 | 4.44 |
Meox2 |
mesenchyme homeobox 2 |
3894 |
0.23 |
chr1_19211603_19212440 | 4.43 |
Tfap2b |
transcription factor AP-2 beta |
33 |
0.98 |
chr9_88068626_88069388 | 4.43 |
Gm28877 |
predicted gene 28877 |
29315 |
0.16 |
chr3_84189998_84191469 | 4.40 |
Trim2 |
tripartite motif-containing 2 |
210 |
0.94 |
chr7_136406153_136406730 | 4.39 |
Gm36849 |
predicted gene, 36849 |
53077 |
0.14 |
chr1_183146101_183147201 | 4.39 |
Disp1 |
dispatched RND transporter family member 1 |
810 |
0.67 |
chr15_101293230_101294713 | 4.36 |
Smim41 |
small integral membrane protein 41 |
739 |
0.47 |
chr2_171735279_171735521 | 4.36 |
1700028P15Rik |
RIKEN cDNA 1700028P15 gene |
226731 |
0.02 |
chr8_107550484_107551505 | 4.36 |
Wwp2 |
WW domain containing E3 ubiquitin protein ligase 2 |
99 |
0.71 |
chr3_54361590_54362355 | 4.35 |
Postn |
periostin, osteoblast specific factor |
829 |
0.74 |
chr5_137610176_137611504 | 4.35 |
Pcolce |
procollagen C-endopeptidase enhancer protein |
138 |
0.86 |
chr9_84113968_84114740 | 4.33 |
Bckdhb |
branched chain ketoacid dehydrogenase E1, beta polypeptide |
6847 |
0.26 |
chr13_95548237_95548815 | 4.32 |
Gm48730 |
predicted gene, 48730 |
12936 |
0.15 |
chr11_50621906_50623031 | 4.31 |
Gm12198 |
predicted gene 12198 |
20020 |
0.17 |
chr2_30851904_30852055 | 4.28 |
Prrx2 |
paired related homeobox 2 |
6535 |
0.13 |
chr3_88547750_88548786 | 4.26 |
Rab25 |
RAB25, member RAS oncogene family |
14 |
0.93 |
chr6_52243632_52244238 | 4.26 |
Hoxa11os |
homeobox A11, opposite strand |
458 |
0.51 |
chr6_83136737_83138439 | 4.24 |
Rtkn |
rhotekin |
478 |
0.52 |
chr10_34483356_34484742 | 4.23 |
Frk |
fyn-related kinase |
517 |
0.83 |
chr1_45311354_45311591 | 4.21 |
Col3a1 |
collagen, type III, alpha 1 |
66 |
0.69 |
chr4_135571917_135572742 | 4.19 |
Grhl3 |
grainyhead like transcription factor 3 |
1301 |
0.37 |
chr6_37418816_37419746 | 4.18 |
Creb3l2 |
cAMP responsive element binding protein 3-like 2 |
22865 |
0.24 |
chr2_74686971_74688120 | 4.17 |
Gm28309 |
predicted gene 28309 |
4099 |
0.06 |
chr7_79847271_79848480 | 4.17 |
Anpep |
alanyl (membrane) aminopeptidase |
308 |
0.83 |
chr17_13867197_13867901 | 4.14 |
Afdn |
afadin, adherens junction formation factor |
67 |
0.97 |
chr13_55830047_55831334 | 4.14 |
Pitx1 |
paired-like homeodomain transcription factor 1 |
735 |
0.57 |
chr18_75374458_75376171 | 4.12 |
Smad7 |
SMAD family member 7 |
400 |
0.87 |
chr5_16554458_16555360 | 4.10 |
Hgf |
hepatocyte growth factor |
981 |
0.56 |
chr7_49528137_49528903 | 4.09 |
Nav2 |
neuron navigator 2 |
19672 |
0.23 |
chr11_88727907_88728443 | 4.08 |
C030037D09Rik |
RIKEN cDNA C030037D09 gene |
7686 |
0.18 |
chr14_110754559_110755226 | 4.08 |
Slitrk6 |
SLIT and NTRK-like family, member 6 |
257 |
0.91 |
chr14_76810574_76811534 | 4.07 |
Gm48968 |
predicted gene, 48968 |
21767 |
0.16 |
chr12_12840455_12841658 | 4.06 |
Gm48187 |
predicted gene, 48187 |
24514 |
0.15 |
chr10_98806784_98807451 | 4.06 |
Atp2b1 |
ATPase, Ca++ transporting, plasma membrane 1 |
107289 |
0.07 |
chr11_111583176_111584131 | 4.05 |
Gm11676 |
predicted gene 11676 |
29653 |
0.25 |
chr11_96849614_96850740 | 4.02 |
Mir152 |
microRNA 152 |
216 |
0.56 |
chr10_8944239_8945864 | 4.01 |
Gm48728 |
predicted gene, 48728 |
6898 |
0.2 |
chr13_55835316_55837389 | 4.00 |
Pitx1 |
paired-like homeodomain transcription factor 1 |
160 |
0.62 |
chr11_100134663_100135612 | 3.99 |
Krt15 |
keratin 15 |
739 |
0.42 |
chrX_53053916_53055220 | 3.97 |
Mir322 |
microRNA 322 |
219 |
0.66 |
chr11_24643482_24643633 | 3.95 |
Gm25507 |
predicted gene, 25507 |
36154 |
0.18 |
chr6_83135616_83136416 | 3.94 |
Rtkn |
rhotekin |
204 |
0.8 |
chr11_16559155_16559706 | 3.94 |
Akt2-ps |
thymoma viral proto-oncogene 2, pseudogene |
44897 |
0.13 |
chr8_26308096_26308272 | 3.93 |
Gm31784 |
predicted gene, 31784 |
4150 |
0.17 |
chr11_54067769_54068952 | 3.93 |
Pdlim4 |
PDZ and LIM domain 4 |
572 |
0.71 |
chr8_118884717_118885310 | 3.92 |
Gm22999 |
predicted gene, 22999 |
158113 |
0.04 |
chr8_61757074_61758475 | 3.90 |
Palld |
palladin, cytoskeletal associated protein |
2315 |
0.38 |
chr7_3292731_3293965 | 3.88 |
Myadm |
myeloid-associated differentiation marker |
254 |
0.81 |
chr3_148336099_148336635 | 3.88 |
Gm23131 |
predicted gene, 23131 |
17851 |
0.28 |
chr6_72248390_72248650 | 3.87 |
Atoh8 |
atonal bHLH transcription factor 8 |
12943 |
0.15 |
chr16_95258137_95259508 | 3.85 |
Kcnj15 |
potassium inwardly-rectifying channel, subfamily J, member 15 |
533 |
0.61 |
chr3_87150105_87151405 | 3.85 |
Gm37855 |
predicted gene, 37855 |
6938 |
0.18 |
chr19_20389423_20390852 | 3.83 |
Anxa1 |
annexin A1 |
514 |
0.81 |
chr5_119673183_119673803 | 3.83 |
Tbx3 |
T-box 3 |
1952 |
0.23 |
chr11_99043636_99045890 | 3.82 |
Igfbp4 |
insulin-like growth factor binding protein 4 |
3 |
0.96 |
chr2_126034531_126036034 | 3.80 |
Fgf7 |
fibroblast growth factor 7 |
309 |
0.93 |
chr3_130086575_130086953 | 3.78 |
Gm42663 |
predicted gene 42663 |
5985 |
0.17 |
chr8_47851685_47852685 | 3.78 |
Cldn22 |
claudin 22 |
27703 |
0.12 |
chr3_116127845_116129091 | 3.76 |
Gm43109 |
predicted gene 43109 |
17 |
0.88 |
chr9_56324598_56325221 | 3.75 |
Gm37842 |
predicted gene, 37842 |
61310 |
0.08 |
chr6_136875262_136875841 | 3.75 |
Mgp |
matrix Gla protein |
230 |
0.87 |
chr8_108027187_108028441 | 3.71 |
Zfhx3 |
zinc finger homeobox 3 |
33255 |
0.23 |
chr3_155944110_155944261 | 3.70 |
9330178D15Rik |
RIKEN cDNA 9330178D15 gene |
32169 |
0.15 |
chr8_27088759_27090036 | 3.69 |
Adgra2 |
adhesion G protein-coupled receptor A2 |
3799 |
0.14 |
chr2_145860106_145862208 | 3.69 |
Rin2 |
Ras and Rab interactor 2 |
1487 |
0.37 |
chr10_8760392_8761253 | 3.69 |
Sash1 |
SAM and SH3 domain containing 1 |
1652 |
0.41 |
chr3_99248252_99249856 | 3.67 |
Tbx15 |
T-box 15 |
4706 |
0.18 |
chr1_135731300_135732728 | 3.65 |
Csrp1 |
cysteine and glycine-rich protein 1 |
2867 |
0.22 |
chr19_43387421_43387870 | 3.61 |
Hpse2 |
heparanase 2 |
609 |
0.73 |
chr9_32542191_32543480 | 3.61 |
Fli1 |
Friend leukemia integration 1 |
26 |
0.96 |
chr3_95498942_95500401 | 3.61 |
Ctsk |
cathepsin K |
415 |
0.72 |
chr9_30920196_30920963 | 3.60 |
Adamts15 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 15 |
371 |
0.88 |
chr7_100924536_100925334 | 3.60 |
Arhgef17 |
Rho guanine nucleotide exchange factor (GEF) 17 |
7172 |
0.15 |
chr9_30918491_30920140 | 3.60 |
Adamts15 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 15 |
1635 |
0.4 |
chr4_63217830_63218342 | 3.60 |
Col27a1 |
collagen, type XXVII, alpha 1 |
2651 |
0.25 |
chr9_21152788_21154079 | 3.59 |
Cdc37 |
cell division cycle 37 |
3451 |
0.12 |
chr15_27777838_27778577 | 3.58 |
Trio |
triple functional domain (PTPRF interacting) |
10431 |
0.23 |
chr3_40483290_40483604 | 3.56 |
1700017G19Rik |
RIKEN cDNA 1700017G19 gene |
26327 |
0.18 |
chr7_27330548_27331710 | 3.55 |
Ltbp4 |
latent transforming growth factor beta binding protein 4 |
2484 |
0.17 |
chr13_56611164_56612950 | 3.55 |
Tgfbi |
transforming growth factor, beta induced |
2471 |
0.28 |
chr13_94062433_94063410 | 3.53 |
Lhfpl2 |
lipoma HMGIC fusion partner-like 2 |
5089 |
0.2 |
chr10_79989757_79990308 | 3.52 |
Cnn2 |
calponin 2 |
1409 |
0.18 |
chr8_119993945_119994662 | 3.51 |
Crispld2 |
cysteine-rich secretory protein LCCL domain containing 2 |
1795 |
0.32 |
chr12_70148053_70148590 | 3.50 |
Abhd12b |
abhydrolase domain containing 12B |
5821 |
0.17 |
chr10_86700286_86701944 | 3.49 |
Hsp90b1 |
heat shock protein 90, beta (Grp94), member 1 |
853 |
0.34 |
chr11_107784245_107784396 | 3.48 |
Gm11650 |
predicted gene 11650 |
9546 |
0.18 |
chr5_105823009_105823559 | 3.48 |
Lrrc8d |
leucine rich repeat containing 8D |
1227 |
0.37 |
chr7_4163531_4164895 | 3.45 |
Cdc42ep5 |
CDC42 effector protein (Rho GTPase binding) 5 |
229 |
0.84 |
chr15_101227850_101228658 | 3.42 |
A330009N23Rik |
RIKEN cDNA A330009N23 gene |
3068 |
0.13 |
chr5_119676129_119676716 | 3.42 |
Tbx3 |
T-box 3 |
977 |
0.47 |
chr2_57919076_57919499 | 3.42 |
Gm33594 |
predicted gene, 33594 |
66730 |
0.11 |
chr4_41760125_41761587 | 3.42 |
Il11ra1 |
interleukin 11 receptor, alpha chain 1 |
344 |
0.75 |
chr10_127341028_127341996 | 3.41 |
Gli1 |
GLI-Kruppel family member GLI1 |
374 |
0.69 |
chrX_106839224_106840351 | 3.40 |
Rtl3 |
retrotransposon Gag like 3 |
857 |
0.6 |
chr7_75781306_75781612 | 3.37 |
AU020206 |
expressed sequence AU020206 |
640 |
0.66 |
chr8_26226590_26227198 | 3.36 |
Gm44299 |
predicted gene, 44299 |
7433 |
0.12 |
chr7_142486780_142486931 | 3.36 |
Lsp1 |
lymphocyte specific 1 |
2162 |
0.18 |
chr9_58128949_58130350 | 3.36 |
Stra6 |
stimulated by retinoic acid gene 6 |
148 |
0.93 |
chr11_19423801_19424837 | 3.36 |
Gm12026 |
predicted gene 12026 |
40634 |
0.18 |
chr1_54906181_54907571 | 3.35 |
A130048G24Rik |
RIKEN cDNA A130048G24 gene |
9718 |
0.19 |
chr4_97774693_97776304 | 3.34 |
Nfia |
nuclear factor I/A |
2110 |
0.3 |
chr10_126144533_126145092 | 3.33 |
Gm4510 |
predicted gene 4510 |
41511 |
0.18 |
chr10_44452907_44453510 | 3.32 |
Prdm1 |
PR domain containing 1, with ZNF domain |
4002 |
0.23 |
chr4_57607259_57607734 | 3.32 |
Pakap |
paralemmin A kinase anchor protein |
30327 |
0.22 |
chr7_81134480_81135027 | 3.31 |
Slc28a1 |
solute carrier family 28 (sodium-coupled nucleoside transporter), member 1 |
19903 |
0.13 |
chr17_46086350_46086741 | 3.30 |
Gm36200 |
predicted gene, 36200 |
2279 |
0.2 |
chr18_80711254_80711893 | 3.29 |
Nfatc1 |
nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 1 |
1193 |
0.45 |
chr15_85207415_85208734 | 3.29 |
Fbln1 |
fibulin 1 |
2069 |
0.32 |
chr8_80055315_80056710 | 3.29 |
Hhip |
Hedgehog-interacting protein |
1994 |
0.35 |
chr8_121116214_121118487 | 3.27 |
Foxc2 |
forkhead box C2 |
1179 |
0.35 |
chr9_43253219_43253445 | 3.27 |
D630033O11Rik |
RIKEN cDNA D630033O11 gene |
6548 |
0.17 |
chr5_137348685_137349851 | 3.27 |
Ephb4 |
Eph receptor B4 |
841 |
0.39 |
chr8_36602981_36604115 | 3.26 |
Dlc1 |
deleted in liver cancer 1 |
10326 |
0.27 |
chr19_43385959_43387401 | 3.26 |
Hpse2 |
heparanase 2 |
1574 |
0.38 |
chr2_167540595_167541629 | 3.26 |
Snai1 |
snail family zinc finger 1 |
2917 |
0.16 |
chr5_125386055_125387945 | 3.24 |
Ubc |
ubiquitin C |
2186 |
0.18 |
chr7_67026286_67026819 | 3.24 |
Adamts17 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 17 |
20919 |
0.17 |
chr7_89908591_89908898 | 3.23 |
Ccdc81 |
coiled-coil domain containing 81 |
5115 |
0.17 |
chr6_5390098_5391379 | 3.23 |
Asb4 |
ankyrin repeat and SOCS box-containing 4 |
311 |
0.93 |
chr19_4720446_4722033 | 3.23 |
Sptbn2 |
spectrin beta, non-erythrocytic 2 |
160 |
0.92 |
chr3_103733809_103735637 | 3.23 |
Olfml3 |
olfactomedin-like 3 |
494 |
0.64 |
chr7_127712115_127712266 | 3.22 |
Ctf1 |
cardiotrophin 1 |
546 |
0.53 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.8 | 7.5 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
3.4 | 17.1 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
2.9 | 8.7 | GO:0072275 | metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
2.8 | 13.8 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
2.5 | 7.6 | GO:0010159 | specification of organ position(GO:0010159) |
2.3 | 9.2 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
2.2 | 8.9 | GO:0060005 | vestibular reflex(GO:0060005) |
2.2 | 12.9 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
1.9 | 5.8 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
1.8 | 5.4 | GO:0002930 | trabecular meshwork development(GO:0002930) |
1.8 | 5.3 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
1.7 | 5.2 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
1.7 | 5.2 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
1.7 | 6.9 | GO:0036486 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
1.6 | 3.2 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
1.6 | 3.2 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
1.6 | 6.4 | GO:0007418 | ventral midline development(GO:0007418) |
1.6 | 6.4 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
1.5 | 6.1 | GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
1.5 | 1.5 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
1.4 | 4.1 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
1.4 | 1.4 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
1.3 | 3.8 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
1.3 | 3.8 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
1.2 | 3.7 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
1.2 | 2.5 | GO:0001757 | somite specification(GO:0001757) |
1.2 | 3.7 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
1.2 | 3.6 | GO:0032474 | otolith morphogenesis(GO:0032474) |
1.2 | 2.4 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
1.2 | 3.6 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
1.2 | 2.3 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
1.1 | 9.2 | GO:0008343 | adult feeding behavior(GO:0008343) |
1.1 | 5.6 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
1.1 | 7.5 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
1.1 | 1.1 | GO:0061626 | pharyngeal arch artery morphogenesis(GO:0061626) |
1.0 | 3.1 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
1.0 | 7.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
1.0 | 3.1 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
1.0 | 3.0 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
1.0 | 1.0 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
1.0 | 2.9 | GO:0015889 | cobalamin transport(GO:0015889) |
1.0 | 2.9 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
1.0 | 5.8 | GO:0048539 | bone marrow development(GO:0048539) |
1.0 | 2.9 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
1.0 | 2.9 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
0.9 | 9.4 | GO:0032060 | bleb assembly(GO:0032060) |
0.9 | 0.9 | GO:0034633 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.9 | 9.3 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.9 | 1.9 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.9 | 0.9 | GO:0060435 | bronchiole development(GO:0060435) |
0.9 | 3.7 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.9 | 4.6 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.9 | 10.0 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.9 | 2.7 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.9 | 2.7 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.9 | 0.9 | GO:0003166 | bundle of His development(GO:0003166) |
0.9 | 0.9 | GO:0061551 | trigeminal ganglion development(GO:0061551) |
0.8 | 3.4 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.8 | 1.7 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.8 | 2.5 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.8 | 9.0 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.8 | 2.5 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.8 | 0.8 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
0.8 | 2.5 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.8 | 1.6 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.8 | 8.1 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.8 | 3.2 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.8 | 3.2 | GO:0072338 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.8 | 2.3 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.8 | 2.3 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.8 | 0.8 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
0.8 | 3.0 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.7 | 3.7 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.7 | 0.7 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.7 | 2.1 | GO:0052490 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.7 | 2.1 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.7 | 1.4 | GO:0031446 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.7 | 3.5 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.7 | 4.2 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
0.7 | 2.1 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.7 | 1.4 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.7 | 7.6 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.7 | 2.8 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.7 | 0.7 | GO:0007512 | adult heart development(GO:0007512) |
0.7 | 6.8 | GO:0046697 | decidualization(GO:0046697) |
0.7 | 2.7 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.7 | 4.1 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.7 | 2.0 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.7 | 8.1 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.7 | 2.0 | GO:1904395 | regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
0.7 | 6.0 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
0.7 | 2.0 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.7 | 3.3 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.6 | 1.3 | GO:0021564 | vagus nerve development(GO:0021564) |
0.6 | 1.3 | GO:0070340 | detection of bacterial lipopeptide(GO:0070340) |
0.6 | 1.9 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.6 | 1.3 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.6 | 4.5 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.6 | 2.5 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.6 | 3.8 | GO:0042482 | positive regulation of odontogenesis(GO:0042482) |
0.6 | 1.9 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.6 | 1.9 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.6 | 0.6 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.6 | 0.6 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.6 | 1.8 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.6 | 0.6 | GO:0071335 | hair follicle cell proliferation(GO:0071335) |
0.6 | 3.5 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) |
0.6 | 1.7 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.6 | 1.2 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.6 | 1.7 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.6 | 1.1 | GO:0021615 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.6 | 1.1 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.6 | 0.6 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
0.6 | 2.8 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.6 | 1.1 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.6 | 0.6 | GO:0014858 | positive regulation of skeletal muscle cell proliferation(GO:0014858) JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.6 | 2.8 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.6 | 3.9 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.6 | 2.2 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.6 | 1.1 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.6 | 1.7 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.6 | 1.1 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.6 | 1.7 | GO:0071899 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.5 | 1.1 | GO:1905005 | regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
0.5 | 0.5 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.5 | 1.6 | GO:1903232 | melanosome assembly(GO:1903232) |
0.5 | 1.6 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.5 | 2.2 | GO:0010957 | negative regulation of vitamin D biosynthetic process(GO:0010957) |
0.5 | 3.2 | GO:0001893 | maternal placenta development(GO:0001893) |
0.5 | 1.1 | GO:0061054 | dermatome development(GO:0061054) regulation of dermatome development(GO:0061183) |
0.5 | 1.0 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.5 | 4.2 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.5 | 1.0 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.5 | 1.0 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
0.5 | 0.5 | GO:0071725 | response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.5 | 2.6 | GO:0035878 | nail development(GO:0035878) |
0.5 | 1.5 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
0.5 | 2.0 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.5 | 10.6 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.5 | 2.0 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.5 | 2.0 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.5 | 1.9 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.5 | 1.5 | GO:0033029 | regulation of neutrophil apoptotic process(GO:0033029) |
0.5 | 1.4 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.5 | 0.5 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
0.5 | 2.4 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
0.5 | 0.5 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.5 | 1.0 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.5 | 1.4 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.5 | 1.4 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.5 | 8.5 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.5 | 2.3 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.5 | 3.3 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.5 | 0.5 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.5 | 0.9 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.5 | 0.5 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.5 | 1.4 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.5 | 5.5 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.5 | 0.9 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.5 | 0.9 | GO:0052173 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.5 | 0.9 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.4 | 0.9 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.4 | 3.5 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.4 | 0.9 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.4 | 1.3 | GO:0033504 | floor plate development(GO:0033504) |
0.4 | 1.3 | GO:1903423 | positive regulation of synaptic vesicle transport(GO:1902805) positive regulation of synaptic vesicle recycling(GO:1903423) |
0.4 | 0.4 | GO:0014900 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.4 | 1.3 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.4 | 5.1 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.4 | 1.7 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.4 | 5.5 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.4 | 6.3 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.4 | 1.2 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.4 | 0.8 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.4 | 0.8 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.4 | 1.2 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.4 | 1.2 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.4 | 1.6 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.4 | 1.2 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.4 | 1.6 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.4 | 1.6 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.4 | 1.6 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.4 | 6.7 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.4 | 0.8 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.4 | 1.2 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.4 | 3.1 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.4 | 0.8 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.4 | 1.1 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.4 | 1.5 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.4 | 2.7 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.4 | 1.1 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
0.4 | 0.4 | GO:0006808 | regulation of nitrogen utilization(GO:0006808) |
0.4 | 0.4 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.4 | 0.4 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.4 | 1.5 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.4 | 2.2 | GO:0097264 | self proteolysis(GO:0097264) |
0.4 | 12.1 | GO:0010761 | fibroblast migration(GO:0010761) |
0.4 | 2.2 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.4 | 1.5 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.4 | 0.7 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.4 | 2.2 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.4 | 1.1 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.4 | 2.2 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.4 | 2.2 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.4 | 1.8 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.4 | 0.4 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.4 | 1.1 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.4 | 1.8 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.4 | 1.8 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.4 | 1.1 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.4 | 0.7 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.4 | 4.6 | GO:0051043 | regulation of membrane protein ectodomain proteolysis(GO:0051043) |
0.4 | 2.1 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.4 | 1.1 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.3 | 1.4 | GO:0033622 | integrin activation(GO:0033622) |
0.3 | 0.3 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.3 | 0.7 | GO:0042637 | catagen(GO:0042637) |
0.3 | 0.3 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.3 | 3.1 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.3 | 1.0 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.3 | 4.4 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.3 | 5.5 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.3 | 0.7 | GO:0003256 | regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003256) |
0.3 | 1.0 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.3 | 1.4 | GO:2000391 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.3 | 0.3 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.3 | 0.7 | GO:0060437 | lung growth(GO:0060437) |
0.3 | 6.1 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.3 | 0.7 | GO:0002159 | desmosome assembly(GO:0002159) |
0.3 | 1.3 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.3 | 1.0 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.3 | 1.0 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.3 | 1.7 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.3 | 1.0 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.3 | 0.3 | GO:1903795 | regulation of inorganic anion transmembrane transport(GO:1903795) |
0.3 | 2.3 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.3 | 1.3 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.3 | 1.0 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.3 | 3.8 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.3 | 1.0 | GO:0043584 | nose development(GO:0043584) |
0.3 | 2.5 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
0.3 | 1.3 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.3 | 1.0 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.3 | 0.9 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) |
0.3 | 1.9 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.3 | 0.6 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.3 | 0.6 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.3 | 1.2 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.3 | 0.9 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.3 | 7.4 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.3 | 0.3 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.3 | 0.3 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
0.3 | 0.9 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.3 | 1.2 | GO:0018214 | protein carboxylation(GO:0018214) |
0.3 | 1.2 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.3 | 1.8 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.3 | 0.3 | GO:0060594 | mammary gland specification(GO:0060594) |
0.3 | 0.9 | GO:0044854 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) |
0.3 | 0.9 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.3 | 0.9 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.3 | 0.6 | GO:0043366 | beta selection(GO:0043366) |
0.3 | 1.8 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.3 | 0.3 | GO:0035697 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
0.3 | 2.3 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.3 | 0.9 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.3 | 0.9 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.3 | 0.3 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.3 | 0.3 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.3 | 0.6 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.3 | 1.4 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.3 | 3.1 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.3 | 1.7 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.3 | 0.8 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.3 | 0.6 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.3 | 2.2 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.3 | 0.6 | GO:1902075 | cellular response to salt(GO:1902075) |
0.3 | 0.6 | GO:0071839 | apoptotic process in bone marrow(GO:0071839) regulation of apoptotic process in bone marrow(GO:0071865) negative regulation of apoptotic process in bone marrow(GO:0071866) |
0.3 | 5.0 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.3 | 0.6 | GO:0030035 | microspike assembly(GO:0030035) |
0.3 | 0.3 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.3 | 0.3 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.3 | 28.8 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
0.3 | 0.8 | GO:0009093 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.3 | 1.1 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.3 | 0.5 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.3 | 3.2 | GO:0046457 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.3 | 2.2 | GO:0060055 | angiogenesis involved in wound healing(GO:0060055) |
0.3 | 1.1 | GO:0031944 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
0.3 | 0.5 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.3 | 0.8 | GO:0003383 | apical constriction(GO:0003383) |
0.3 | 0.5 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
0.3 | 0.5 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.3 | 0.3 | GO:0021648 | vestibulocochlear nerve morphogenesis(GO:0021648) |
0.3 | 0.3 | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.3 | 1.0 | GO:0061037 | negative regulation of cartilage development(GO:0061037) |
0.3 | 0.5 | GO:2000562 | CD4-positive, alpha-beta T cell proliferation(GO:0035739) regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.3 | 3.1 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.3 | 0.5 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.3 | 0.3 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.3 | 0.3 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.3 | 0.8 | GO:0072093 | ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
0.3 | 0.8 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.2 | 1.5 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.2 | 0.7 | GO:0055015 | ventricular cardiac muscle cell development(GO:0055015) |
0.2 | 0.2 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.2 | 0.7 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.2 | 1.0 | GO:0018158 | protein oxidation(GO:0018158) |
0.2 | 0.5 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
0.2 | 1.2 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.2 | 1.5 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.2 | 0.7 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.2 | 0.2 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.2 | 0.5 | GO:2000347 | positive regulation of hepatocyte proliferation(GO:2000347) |
0.2 | 1.0 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.2 | 1.0 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.2 | 0.7 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.2 | 0.5 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.2 | 1.0 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.2 | 0.5 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.2 | 0.7 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.2 | 2.6 | GO:0001945 | lymph vessel development(GO:0001945) |
0.2 | 0.9 | GO:0070842 | aggresome assembly(GO:0070842) |
0.2 | 0.7 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.2 | 0.5 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.2 | 0.7 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.2 | 0.9 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.2 | 0.2 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.2 | 0.9 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.2 | 0.5 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.2 | 3.2 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.2 | 0.7 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.2 | 0.7 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.2 | 0.9 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.2 | 1.1 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.2 | 0.2 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.2 | 0.7 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.2 | 0.2 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.2 | 0.5 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.2 | 2.0 | GO:0030903 | notochord development(GO:0030903) |
0.2 | 0.2 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.2 | 0.4 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.2 | 0.9 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.2 | 3.5 | GO:0050687 | negative regulation of defense response to virus(GO:0050687) |
0.2 | 0.9 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.2 | 0.4 | GO:0051594 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.2 | 1.7 | GO:0070920 | regulation of production of small RNA involved in gene silencing by RNA(GO:0070920) |
0.2 | 1.3 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.2 | 1.3 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.2 | 12.2 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.2 | 0.7 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.2 | 0.6 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.2 | 0.9 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.2 | 0.4 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.2 | 1.1 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.2 | 1.3 | GO:0007398 | ectoderm development(GO:0007398) |
0.2 | 0.9 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.2 | 0.6 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.2 | 2.1 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.2 | 0.4 | GO:2000020 | positive regulation of male gonad development(GO:2000020) |
0.2 | 1.3 | GO:0010896 | regulation of triglyceride catabolic process(GO:0010896) positive regulation of triglyceride catabolic process(GO:0010898) |
0.2 | 1.1 | GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway(GO:0040036) |
0.2 | 0.6 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.2 | 0.8 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.2 | 0.4 | GO:0014891 | striated muscle atrophy(GO:0014891) |
0.2 | 1.0 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.2 | 1.2 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.2 | 0.4 | GO:0060525 | prostate glandular acinus development(GO:0060525) |
0.2 | 1.7 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.2 | 0.4 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.2 | 0.6 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.2 | 0.4 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.2 | 0.6 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.2 | 0.2 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.2 | 0.6 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.2 | 0.6 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.2 | 0.2 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.2 | 0.8 | GO:0032963 | collagen metabolic process(GO:0032963) |
0.2 | 0.2 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) |
0.2 | 4.7 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.2 | 6.6 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.2 | 1.0 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.2 | 0.4 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.2 | 0.6 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.2 | 0.4 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.2 | 0.2 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.2 | 1.4 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.2 | 0.4 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.2 | 0.8 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.2 | 0.6 | GO:0048478 | replication fork protection(GO:0048478) |
0.2 | 0.6 | GO:0072102 | glomerulus morphogenesis(GO:0072102) |
0.2 | 0.2 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.2 | 4.0 | GO:0034340 | response to type I interferon(GO:0034340) |
0.2 | 0.2 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) |
0.2 | 0.4 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.2 | 4.7 | GO:0002062 | chondrocyte differentiation(GO:0002062) |
0.2 | 1.1 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.2 | 0.4 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.2 | 0.2 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.2 | 0.2 | GO:0072107 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
0.2 | 0.2 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.2 | 0.2 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.2 | 0.4 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.2 | 0.6 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.2 | 0.7 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.2 | 0.4 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.2 | 0.7 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.2 | 0.2 | GO:0044026 | DNA hypermethylation(GO:0044026) |
0.2 | 0.7 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.2 | 0.4 | GO:1901163 | regulation of trophoblast cell migration(GO:1901163) |
0.2 | 0.4 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.2 | 0.9 | GO:0006684 | sphingomyelin metabolic process(GO:0006684) |
0.2 | 0.4 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.2 | 0.5 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.2 | 0.4 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.2 | 0.4 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.2 | 0.5 | GO:0046909 | intermembrane transport(GO:0046909) |
0.2 | 0.2 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.2 | 1.4 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.2 | 0.5 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.2 | 0.7 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.2 | 0.3 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
0.2 | 0.2 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.2 | 0.5 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.2 | 1.4 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.2 | 1.2 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.2 | 0.5 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.2 | 2.1 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.2 | 0.3 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.2 | 0.2 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.2 | 0.3 | GO:0060290 | transdifferentiation(GO:0060290) |
0.2 | 0.5 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.2 | 0.3 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.2 | 0.2 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.2 | 0.3 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.2 | 0.7 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.2 | 2.2 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.2 | 0.5 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.2 | 0.8 | GO:0051775 | response to redox state(GO:0051775) |
0.2 | 0.2 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) protein transport into membrane raft(GO:0032596) |
0.2 | 1.8 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.2 | 2.0 | GO:0002347 | response to tumor cell(GO:0002347) |
0.2 | 5.3 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.2 | 0.7 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.2 | 0.2 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.2 | 0.5 | GO:2001028 | positive regulation of endothelial cell chemotaxis(GO:2001028) |
0.2 | 0.5 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.2 | 1.7 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.2 | 0.5 | GO:0007525 | somatic muscle development(GO:0007525) |
0.2 | 0.2 | GO:0032960 | regulation of inositol trisphosphate biosynthetic process(GO:0032960) positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
0.2 | 0.2 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.2 | 0.8 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.2 | 0.3 | GO:0061035 | regulation of cartilage development(GO:0061035) |
0.2 | 0.2 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.2 | 1.0 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.2 | 0.3 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
0.2 | 0.7 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.2 | 1.0 | GO:0007144 | female meiosis I(GO:0007144) |
0.2 | 0.3 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.2 | 1.0 | GO:0016266 | O-glycan processing(GO:0016266) |
0.2 | 0.8 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.2 | 0.3 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.2 | 1.6 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.2 | 0.6 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.2 | 0.5 | GO:0015744 | succinate transport(GO:0015744) |
0.2 | 0.6 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.2 | 0.5 | GO:0016264 | gap junction assembly(GO:0016264) |
0.2 | 0.5 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.2 | 0.5 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.2 | 0.3 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.2 | 1.6 | GO:0018904 | ether metabolic process(GO:0018904) |
0.2 | 0.6 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.2 | 0.5 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.2 | 6.0 | GO:0030282 | bone mineralization(GO:0030282) |
0.2 | 0.3 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.2 | 1.3 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.2 | 0.5 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.2 | 0.2 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
0.2 | 0.5 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.2 | 0.5 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.2 | 0.5 | GO:0042427 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.2 | 1.9 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.2 | 1.6 | GO:0060147 | regulation of posttranscriptional gene silencing(GO:0060147) regulation of gene silencing by miRNA(GO:0060964) regulation of gene silencing by RNA(GO:0060966) |
0.2 | 0.2 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.2 | 0.3 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.2 | 0.3 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.2 | 0.6 | GO:0097421 | liver regeneration(GO:0097421) |
0.2 | 0.3 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.2 | 0.3 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.2 | 0.5 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.2 | 0.2 | GO:0072683 | T cell extravasation(GO:0072683) regulation of T cell extravasation(GO:2000407) |
0.2 | 0.3 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.2 | 0.5 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.2 | 1.5 | GO:0043149 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
0.2 | 0.5 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.2 | 0.2 | GO:0040038 | polar body extrusion after meiotic divisions(GO:0040038) |
0.2 | 2.0 | GO:1901186 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.2 | 0.8 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.2 | 0.6 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.1 | 0.1 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.1 | 0.3 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.1 | 0.4 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.1 | 1.2 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.1 | 0.1 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.1 | 0.1 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.1 | 0.6 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.1 | 0.6 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.1 | 0.4 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.1 | 0.1 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.1 | 0.9 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.1 | 0.9 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 0.1 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.1 | 0.4 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.1 | 0.3 | GO:0042891 | antibiotic transport(GO:0042891) |
0.1 | 0.1 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.1 | 2.2 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.1 | 0.3 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.1 | 0.7 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.1 | 0.6 | GO:0072577 | endothelial cell apoptotic process(GO:0072577) |
0.1 | 0.4 | GO:0060914 | heart formation(GO:0060914) |
0.1 | 0.4 | GO:0046959 | habituation(GO:0046959) |
0.1 | 0.1 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.1 | 0.3 | GO:0043032 | positive regulation of macrophage activation(GO:0043032) |
0.1 | 0.3 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.1 | 0.3 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.1 | 0.8 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.1 | 2.7 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.3 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.1 | 0.6 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.1 | 0.4 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.1 | 0.4 | GO:0060264 | regulation of respiratory burst involved in inflammatory response(GO:0060264) |
0.1 | 0.1 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 3.7 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.1 | 0.3 | GO:0090399 | replicative senescence(GO:0090399) |
0.1 | 0.3 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.1 | 0.8 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.1 | 1.2 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.1 | 0.8 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.1 | 0.1 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.1 | 0.3 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
0.1 | 0.5 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.1 | 0.1 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.1 | 0.5 | GO:0060325 | face morphogenesis(GO:0060325) |
0.1 | 0.5 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) positive regulation of histone ubiquitination(GO:0033184) |
0.1 | 0.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 2.1 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.1 | 0.1 | GO:0031657 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.1 | 3.4 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
0.1 | 0.1 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
0.1 | 0.4 | GO:0031000 | response to caffeine(GO:0031000) |
0.1 | 0.1 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
0.1 | 0.1 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.1 | 0.4 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.1 | 0.1 | GO:0097278 | complement-dependent cytotoxicity(GO:0097278) |
0.1 | 0.4 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.1 | 0.5 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.1 | 1.0 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.1 | 0.3 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.1 | 1.3 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.1 | 0.9 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.1 | 0.1 | GO:0098868 | bone growth(GO:0098868) |
0.1 | 0.4 | GO:0044351 | macropinocytosis(GO:0044351) |
0.1 | 0.4 | GO:0014857 | regulation of skeletal muscle cell proliferation(GO:0014857) |
0.1 | 0.5 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 | 9.4 | GO:0030198 | extracellular matrix organization(GO:0030198) |
0.1 | 0.1 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.1 | 0.1 | GO:0032909 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.1 | 0.2 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.1 | 2.0 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.1 | 0.7 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.1 | 0.7 | GO:2000778 | positive regulation of interleukin-6 secretion(GO:2000778) |
0.1 | 0.1 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.1 | 0.4 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.5 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.1 | 0.9 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 0.4 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.1 | 0.2 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.1 | 0.7 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.1 | 0.2 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) |
0.1 | 0.1 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.1 | 2.1 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.1 | 1.1 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 0.2 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.1 | 0.6 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.1 | 0.4 | GO:0048865 | stem cell fate commitment(GO:0048865) |
0.1 | 0.2 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 0.1 | GO:0060343 | trabecula formation(GO:0060343) |
0.1 | 1.2 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 1.1 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.1 | GO:0043309 | regulation of eosinophil degranulation(GO:0043309) |
0.1 | 0.4 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.1 | 0.5 | GO:0030812 | negative regulation of nucleotide catabolic process(GO:0030812) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
0.1 | 0.5 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.1 | 0.1 | GO:0043307 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil activation(GO:0043307) eosinophil degranulation(GO:0043308) |
0.1 | 0.6 | GO:0046836 | glycolipid transport(GO:0046836) |
0.1 | 0.2 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.1 | 0.5 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.1 | 0.2 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.1 | 0.3 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.1 | 1.0 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.1 | 0.3 | GO:0009173 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.1 | 0.1 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
0.1 | 0.3 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.1 | 0.3 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 0.5 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.1 | 0.1 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.1 | 0.1 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.1 | 0.3 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.1 | 0.3 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.1 | 0.6 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.1 | 0.6 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.2 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.2 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.1 | 0.2 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.1 | 0.8 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.1 | 0.3 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.1 | 0.3 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.1 | 0.1 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.1 | 1.0 | GO:0014850 | response to muscle activity(GO:0014850) |
0.1 | 0.9 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.8 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.1 | 1.4 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
0.1 | 0.1 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
0.1 | 0.2 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.1 | 0.7 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.1 | 0.4 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.1 | 0.5 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.1 | 0.2 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.1 | 0.4 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 2.9 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.8 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.1 | 1.2 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.1 | 0.5 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.2 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.1 | 0.2 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.1 | 0.2 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.1 | 1.4 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 0.2 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.1 | 0.1 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.1 | 0.1 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.1 | 0.5 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.1 | 0.5 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.1 | 0.2 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.1 | 0.2 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.1 | 0.8 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.1 | 0.1 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.1 | 0.2 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 0.5 | GO:0060349 | bone morphogenesis(GO:0060349) |
0.1 | 0.5 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.1 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.1 | 1.4 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.1 | 0.8 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 0.3 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.1 | 0.4 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.1 | 0.4 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.1 | 0.1 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.1 | 0.6 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.1 | 0.3 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.1 | 0.6 | GO:0010954 | positive regulation of protein processing(GO:0010954) |
0.1 | 0.2 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.1 | 0.4 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
0.1 | 0.2 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) negative regulation of ribosome biogenesis(GO:0090071) |
0.1 | 0.4 | GO:0015858 | nucleoside transport(GO:0015858) |
0.1 | 0.3 | GO:0019695 | choline metabolic process(GO:0019695) |
0.1 | 0.2 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.1 | 1.1 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.1 | 0.1 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.1 | 0.1 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.1 | 1.0 | GO:0033273 | response to vitamin(GO:0033273) |
0.1 | 0.4 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.1 | 1.0 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.3 | GO:0061083 | regulation of protein refolding(GO:0061083) |
0.1 | 0.1 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.1 | 0.3 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.1 | 0.4 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.1 | 0.4 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 0.3 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
0.1 | 0.5 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.1 | 0.4 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.1 | 3.5 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) |
0.1 | 2.3 | GO:0030326 | embryonic limb morphogenesis(GO:0030326) embryonic appendage morphogenesis(GO:0035113) |
0.1 | 0.2 | GO:1902837 | amino acid import into cell(GO:1902837) |
0.1 | 0.4 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 0.3 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.1 | 0.3 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.1 | 0.3 | GO:0048333 | mesodermal cell differentiation(GO:0048333) |
0.1 | 0.2 | GO:0035973 | aggrephagy(GO:0035973) |
0.1 | 0.3 | GO:0031627 | telomeric loop formation(GO:0031627) |
0.1 | 0.4 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 0.2 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.1 | 0.3 | GO:0006116 | NADH oxidation(GO:0006116) |
0.1 | 1.2 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.1 | 0.3 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.1 | 0.4 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.1 | 0.3 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.1 | 0.2 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
0.1 | 0.1 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.1 | 0.3 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.1 | 0.1 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
0.1 | 0.3 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.1 | 1.4 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.1 | 0.3 | GO:0009158 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.1 | 1.7 | GO:1903845 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
0.1 | 0.8 | GO:1903844 | regulation of transforming growth factor beta receptor signaling pathway(GO:0017015) regulation of cellular response to transforming growth factor beta stimulus(GO:1903844) |
0.1 | 0.1 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.1 | 0.2 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.1 | 1.0 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.1 | 0.4 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) |
0.1 | 0.1 | GO:0036258 | multivesicular body organization(GO:0036257) multivesicular body assembly(GO:0036258) late endosomal microautophagy(GO:0061738) |
0.1 | 0.2 | GO:0072422 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.1 | 0.3 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 0.2 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.1 | 0.1 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
0.1 | 1.2 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.5 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
0.1 | 0.3 | GO:0050927 | positive regulation of positive chemotaxis(GO:0050927) |
0.1 | 0.3 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.1 | 0.1 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.1 | 0.1 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.1 | 0.5 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.1 | 0.3 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.1 | 0.4 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.1 | 0.3 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.1 | 1.0 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.1 | 0.1 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.1 | 0.1 | GO:0060100 | positive regulation of phagocytosis, engulfment(GO:0060100) positive regulation of membrane invagination(GO:1905155) |
0.1 | 0.1 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.1 | 0.1 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.1 | 0.2 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.1 | 0.2 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.1 | 0.3 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.1 | 0.4 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.1 | 0.1 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.1 | 0.3 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.1 | 0.6 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.1 | 0.1 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.1 | 0.3 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
0.1 | 0.2 | GO:0070723 | cellular response to sterol(GO:0036315) response to cholesterol(GO:0070723) |
0.1 | 0.2 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.3 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.1 | 0.8 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.1 | 0.3 | GO:0090303 | positive regulation of wound healing(GO:0090303) |
0.1 | 0.3 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.1 | 0.1 | GO:0035931 | mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) regulation of aldosterone secretion(GO:2000858) |
0.1 | 0.3 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.1 | 0.1 | GO:0008050 | courtship behavior(GO:0007619) female courtship behavior(GO:0008050) |
0.1 | 0.4 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.1 | 0.4 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 0.6 | GO:0046514 | ceramide catabolic process(GO:0046514) |
0.1 | 0.3 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.1 | 0.6 | GO:0000338 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.1 | 1.0 | GO:0051148 | negative regulation of muscle cell differentiation(GO:0051148) |
0.1 | 0.2 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.1 | 0.2 | GO:0003170 | heart valve development(GO:0003170) |
0.1 | 0.2 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.1 | 0.6 | GO:0015825 | L-serine transport(GO:0015825) |
0.1 | 0.4 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 0.2 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.1 | 0.5 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
0.1 | 0.3 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 0.3 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.1 | 0.1 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.1 | 0.3 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.1 | 0.1 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
0.1 | 0.2 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.1 | 0.2 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.1 | 0.1 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.1 | 0.3 | GO:0015671 | oxygen transport(GO:0015671) |
0.1 | 0.7 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.1 | 0.3 | GO:0048254 | snoRNA localization(GO:0048254) |
0.1 | 1.2 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.1 | 0.2 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.1 | 0.2 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.1 | 0.5 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.1 | 0.3 | GO:1904970 | brush border assembly(GO:1904970) |
0.1 | 0.3 | GO:0090504 | epiboly(GO:0090504) |
0.1 | 0.2 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.1 | 0.2 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.1 | 0.8 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.1 | GO:1903209 | positive regulation of oxidative stress-induced cell death(GO:1903209) |
0.1 | 0.2 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.1 | 0.1 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.1 | 0.4 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 | 0.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.1 | 0.4 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 0.3 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.1 | 0.1 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.1 | 0.1 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.1 | 0.1 | GO:0032329 | serine transport(GO:0032329) |
0.1 | 0.6 | GO:0048705 | skeletal system morphogenesis(GO:0048705) |
0.1 | 0.1 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.1 | 1.5 | GO:0015893 | drug transport(GO:0015893) |
0.1 | 0.7 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.1 | 0.4 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.1 | 0.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.3 | GO:0097461 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
0.1 | 0.4 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.1 | 2.7 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.1 | 0.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.1 | 0.2 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.1 | 0.4 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) |
0.1 | 0.1 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
0.1 | 0.3 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.1 | 0.1 | GO:0015755 | fructose transport(GO:0015755) |
0.1 | 0.5 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.1 | 0.4 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.1 | 0.2 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) |
0.1 | 1.1 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.1 | 0.4 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.1 | 0.3 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.1 | 0.2 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.1 | 0.7 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 0.9 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 0.2 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.1 | 0.2 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.1 | 0.1 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.1 | 0.2 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.1 | 0.3 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.1 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.1 | 0.5 | GO:0016556 | mRNA modification(GO:0016556) |
0.1 | 0.3 | GO:0007097 | nuclear migration(GO:0007097) |
0.1 | 0.4 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.1 | 0.1 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.1 | 0.2 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.1 | 0.8 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
0.1 | 0.3 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.1 | 0.3 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.1 | 0.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 0.1 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.1 | 0.2 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.1 | 1.1 | GO:0048286 | lung alveolus development(GO:0048286) |
0.1 | 0.1 | GO:0006311 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.1 | 1.8 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.1 | 0.1 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.1 | 0.3 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.1 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.1 | 0.2 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.1 | 0.1 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.1 | 0.1 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.1 | 0.2 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.1 | 0.1 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) regulation of protein glycosylation in Golgi(GO:0090283) |
0.1 | 0.1 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.1 | 0.1 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.1 | 0.1 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.1 | 0.1 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.5 | GO:0030330 | DNA damage response, signal transduction by p53 class mediator(GO:0030330) |
0.1 | 0.4 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.1 | 0.7 | GO:0008272 | sulfate transport(GO:0008272) |
0.1 | 0.3 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 0.1 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.1 | 0.2 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 0.3 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 0.2 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.1 | 0.1 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.1 | 0.1 | GO:2000647 | negative regulation of stem cell proliferation(GO:2000647) |
0.1 | 0.1 | GO:2000002 | negative regulation of DNA damage checkpoint(GO:2000002) |
0.1 | 0.1 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.1 | 0.1 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.1 | 0.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 0.6 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.1 | 0.2 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.1 | 0.1 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.1 | 0.1 | GO:0071863 | regulation of cell proliferation in bone marrow(GO:0071863) |
0.1 | 0.7 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.1 | 0.2 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.1 | 0.2 | GO:0051031 | tRNA transport(GO:0051031) |
0.1 | 0.1 | GO:0060065 | uterus development(GO:0060065) |
0.1 | 0.2 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.1 | 0.2 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 0.2 | GO:0097178 | ruffle assembly(GO:0097178) |
0.1 | 0.2 | GO:0060135 | maternal process involved in female pregnancy(GO:0060135) |
0.1 | 0.3 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.1 | 0.2 | GO:0045006 | DNA deamination(GO:0045006) |
0.1 | 0.5 | GO:0045581 | negative regulation of T cell differentiation(GO:0045581) |
0.1 | 0.8 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.3 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.1 | 0.2 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.1 | 0.8 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 0.1 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.1 | 0.1 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) |
0.1 | 0.1 | GO:0045714 | low-density lipoprotein particle receptor biosynthetic process(GO:0045713) regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
0.1 | 0.1 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.1 | 0.2 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.1 | 0.1 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.1 | 0.3 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
0.1 | 0.2 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.1 | 0.1 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.1 | 0.2 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.1 | 0.2 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.1 | 0.1 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.1 | 2.1 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.1 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.1 | 0.1 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.1 | 0.1 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 0.1 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.1 | 0.3 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.2 | GO:0048069 | eye pigmentation(GO:0048069) |
0.1 | 0.1 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.1 | 0.3 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.1 | 0.2 | GO:0046110 | xanthine catabolic process(GO:0009115) xanthine metabolic process(GO:0046110) |
0.1 | 0.3 | GO:0071569 | protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.1 | 0.1 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.1 | 0.4 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.1 | 0.1 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.1 | 1.4 | GO:0006342 | chromatin silencing(GO:0006342) |
0.1 | 0.1 | GO:0010872 | regulation of cholesterol esterification(GO:0010872) |
0.1 | 0.1 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.1 | 0.2 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.1 | 0.4 | GO:0043486 | histone exchange(GO:0043486) |
0.1 | 0.7 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.1 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.1 | 0.6 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.1 | 0.1 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.1 | 0.3 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.1 | 0.4 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.1 | 0.3 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.1 | 0.1 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.1 | 0.5 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.1 | 0.3 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 0.1 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.1 | 0.2 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.1 | 0.2 | GO:0031643 | positive regulation of myelination(GO:0031643) |
0.1 | 0.1 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.1 | 0.1 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
0.1 | 0.3 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.1 | 0.3 | GO:0051189 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.4 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) |
0.1 | 0.3 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 0.1 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.1 | 0.2 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.2 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.2 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.0 | 0.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.0 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) |
0.0 | 0.1 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.0 | 0.1 | GO:0060022 | hard palate development(GO:0060022) |
0.0 | 0.1 | GO:0046130 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.0 | 0.0 | GO:0045472 | response to ether(GO:0045472) |
0.0 | 0.2 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.0 | 0.4 | GO:0034030 | coenzyme A biosynthetic process(GO:0015937) nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.0 | 0.5 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.0 | 0.4 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.0 | 0.1 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.0 | 0.0 | GO:0060242 | contact inhibition(GO:0060242) |
0.0 | 0.0 | GO:0048850 | hypophysis morphogenesis(GO:0048850) somatotropin secreting cell differentiation(GO:0060126) |
0.0 | 0.0 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.0 | 0.1 | GO:1901679 | nucleotide transmembrane transport(GO:1901679) |
0.0 | 0.2 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.0 | 0.7 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.0 | 0.1 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.0 | 0.1 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.0 | 0.7 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.6 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.0 | 0.5 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.0 | 0.1 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.0 | 0.1 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.0 | 0.0 | GO:0060008 | Sertoli cell differentiation(GO:0060008) |
0.0 | 0.4 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.0 | 0.0 | GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis(GO:0061309) |
0.0 | 0.1 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.0 | 1.2 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.0 | 0.5 | GO:0006743 | ubiquinone metabolic process(GO:0006743) quinone biosynthetic process(GO:1901663) |
0.0 | 1.0 | GO:0071559 | response to transforming growth factor beta(GO:0071559) |
0.0 | 0.1 | GO:0098751 | bone cell development(GO:0098751) |
0.0 | 0.5 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
0.0 | 0.1 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.0 | 0.2 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.0 | 0.1 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.0 | 0.0 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.0 | 0.1 | GO:0006983 | ER overload response(GO:0006983) |
0.0 | 0.0 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.0 | 0.1 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.0 | 0.3 | GO:0002639 | positive regulation of immunoglobulin production(GO:0002639) |
0.0 | 0.0 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.0 | 0.1 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.0 | 0.0 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.0 | 1.7 | GO:0003341 | cilium movement(GO:0003341) |
0.0 | 0.3 | GO:0031641 | regulation of myelination(GO:0031641) |
0.0 | 0.9 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.0 | 0.2 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.0 | 0.5 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) regulation of spindle organization(GO:0090224) |
0.0 | 0.1 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
0.0 | 0.3 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.0 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.0 | 0.1 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.0 | 0.0 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 0.1 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.0 | 0.8 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.2 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.0 | 0.0 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.0 | 0.0 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.1 | GO:0006921 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.0 | 0.5 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
0.0 | 0.9 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.0 | 0.1 | GO:0072429 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.0 | 0.0 | GO:0002884 | regulation of type IV hypersensitivity(GO:0001807) negative regulation of hypersensitivity(GO:0002884) |
0.0 | 0.1 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.0 | 0.2 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.0 | 0.0 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.0 | 0.3 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) |
0.0 | 0.1 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.0 | 0.1 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.0 | 0.3 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
0.0 | 0.4 | GO:0009303 | rRNA transcription(GO:0009303) |
0.0 | 0.0 | GO:0090032 | negative regulation of steroid hormone biosynthetic process(GO:0090032) |
0.0 | 0.2 | GO:0036065 | fucosylation(GO:0036065) |
0.0 | 0.3 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
0.0 | 0.0 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.0 | 0.0 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.0 | 0.2 | GO:0015879 | carnitine transport(GO:0015879) |
0.0 | 0.5 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.0 | 0.1 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.0 | 0.2 | GO:1901796 | regulation of signal transduction by p53 class mediator(GO:1901796) |
0.0 | 0.1 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.0 | 0.2 | GO:0070986 | left/right axis specification(GO:0070986) |
0.0 | 0.2 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.0 | 0.1 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.0 | 0.1 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.0 | 0.3 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.1 | GO:1904938 | dopaminergic neuron axon guidance(GO:0036514) planar cell polarity pathway involved in axon guidance(GO:1904938) |
0.0 | 0.2 | GO:0016559 | peroxisome fission(GO:0016559) |
0.0 | 0.1 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.0 | 0.2 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.0 | 0.0 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.0 | 0.1 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
0.0 | 0.0 | GO:0016115 | terpenoid catabolic process(GO:0016115) |
0.0 | 0.0 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.0 | 0.0 | GO:0032847 | regulation of cellular pH reduction(GO:0032847) positive regulation of cellular pH reduction(GO:0032849) |
0.0 | 0.0 | GO:0001842 | neural fold formation(GO:0001842) |
0.0 | 0.1 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.0 | 0.1 | GO:0060285 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.0 | 0.0 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
0.0 | 0.0 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.0 | 0.6 | GO:0001936 | regulation of endothelial cell proliferation(GO:0001936) |
0.0 | 0.2 | GO:0060142 | regulation of syncytium formation by plasma membrane fusion(GO:0060142) |
0.0 | 0.2 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.0 | 0.0 | GO:0045354 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.0 | 0.5 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 0.1 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.0 | 0.4 | GO:0006306 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.0 | 0.1 | GO:1901299 | negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
0.0 | 0.1 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 0.0 | GO:0008212 | mineralocorticoid metabolic process(GO:0008212) |
0.0 | 0.3 | GO:0048821 | erythrocyte development(GO:0048821) |
0.0 | 0.1 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.0 | 0.1 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.0 | 0.0 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.0 | 0.1 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.0 | 0.1 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.0 | 0.6 | GO:0007569 | cell aging(GO:0007569) |
0.0 | 0.1 | GO:0050755 | chemokine metabolic process(GO:0050755) |
0.0 | 0.0 | GO:0051349 | positive regulation of lyase activity(GO:0051349) |
0.0 | 0.1 | GO:0043485 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.0 | 0.1 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
0.0 | 0.1 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.1 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.0 | 0.4 | GO:0070527 | platelet aggregation(GO:0070527) |
0.0 | 0.2 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 0.1 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.0 | 0.0 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.0 | 0.7 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.0 | 0.3 | GO:0051601 | exocyst localization(GO:0051601) |
0.0 | 0.0 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.0 | 0.1 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.0 | 0.0 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.0 | 0.0 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.0 | 0.1 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.0 | 0.1 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
0.0 | 0.3 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.0 | 0.3 | GO:0070206 | protein trimerization(GO:0070206) |
0.0 | 0.1 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.1 | GO:0036230 | granulocyte activation(GO:0036230) |
0.0 | 0.0 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.0 | 0.1 | GO:0045762 | positive regulation of adenylate cyclase activity(GO:0045762) |
0.0 | 0.2 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.0 | 0.0 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.0 | 0.1 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.0 | 0.0 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
0.0 | 0.0 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.0 | 0.0 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.0 | 0.4 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.0 | 0.1 | GO:0045661 | regulation of myoblast differentiation(GO:0045661) |
0.0 | 0.0 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.0 | 0.5 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.0 | 0.1 | GO:0045297 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.0 | 0.3 | GO:0034389 | lipid particle organization(GO:0034389) |
0.0 | 0.1 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.0 | 0.1 | GO:0034651 | cortisol biosynthetic process(GO:0034651) |
0.0 | 0.0 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.0 | 0.1 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.0 | 0.1 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.0 | 0.4 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.0 | 0.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.0 | 0.0 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.0 | 0.2 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
0.0 | 0.0 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.0 | 0.2 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.0 | 0.1 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.0 | 0.3 | GO:0050891 | multicellular organismal water homeostasis(GO:0050891) |
0.0 | 0.1 | GO:0002076 | osteoblast development(GO:0002076) |
0.0 | 0.4 | GO:0007031 | peroxisome organization(GO:0007031) |
0.0 | 0.1 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.0 | 0.2 | GO:0010824 | regulation of centrosome duplication(GO:0010824) |
0.0 | 0.0 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
0.0 | 0.1 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.0 | 0.0 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.0 | 0.0 | GO:0014741 | negative regulation of muscle hypertrophy(GO:0014741) |
0.0 | 0.2 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.0 | 0.0 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.0 | 0.0 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.0 | 0.0 | GO:0009092 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
0.0 | 0.0 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.0 | 0.2 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.0 | 0.0 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.0 | 0.0 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.0 | 0.1 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.0 | 0.0 | GO:0071351 | cellular response to interleukin-18(GO:0071351) |
0.0 | 0.2 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.0 | GO:0045922 | negative regulation of fatty acid metabolic process(GO:0045922) |
0.0 | 0.2 | GO:0051216 | cartilage development(GO:0051216) |
0.0 | 0.4 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.0 | 0.0 | GO:0002351 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) |
0.0 | 0.0 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.0 | 0.2 | GO:0051383 | kinetochore organization(GO:0051383) |
0.0 | 0.0 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.0 | 0.1 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.0 | 0.1 | GO:0035108 | appendage morphogenesis(GO:0035107) limb morphogenesis(GO:0035108) |
0.0 | 0.0 | GO:1901264 | carbohydrate derivative transport(GO:1901264) |
0.0 | 0.0 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
0.0 | 0.1 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.0 | 0.1 | GO:0051181 | cofactor transport(GO:0051181) |
0.0 | 0.0 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.0 | 0.4 | GO:0019835 | cytolysis(GO:0019835) |
0.0 | 0.2 | GO:1900003 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.2 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.0 | 0.0 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.0 | 0.0 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.0 | 0.0 | GO:1902931 | negative regulation of alcohol biosynthetic process(GO:1902931) |
0.0 | 0.5 | GO:0001890 | placenta development(GO:0001890) |
0.0 | 0.1 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.0 | 0.1 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.0 | GO:1904037 | positive regulation of epithelial cell apoptotic process(GO:1904037) |
0.0 | 0.7 | GO:0051168 | nuclear export(GO:0051168) |
0.0 | 0.0 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.0 | 0.5 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.0 | 0.0 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.0 | 0.1 | GO:0032367 | intracellular cholesterol transport(GO:0032367) |
0.0 | 0.0 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.0 | 0.0 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.0 | 0.1 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.0 | 0.0 | GO:1900117 | regulation of execution phase of apoptosis(GO:1900117) |
0.0 | 0.0 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.0 | 0.0 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.0 | 0.0 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.0 | 0.0 | GO:2000425 | regulation of apoptotic cell clearance(GO:2000425) positive regulation of apoptotic cell clearance(GO:2000427) |
0.0 | 0.2 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.1 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.0 | 0.2 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 0.1 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.0 | 0.1 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 0.0 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.0 | 0.0 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.0 | 0.0 | GO:0070944 | neutrophil mediated killing of bacterium(GO:0070944) |
0.0 | 0.0 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.0 | 0.0 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.0 | 0.0 | GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
0.0 | 0.2 | GO:0048599 | oocyte development(GO:0048599) |
0.0 | 0.0 | GO:0002086 | diaphragm contraction(GO:0002086) |
0.0 | 0.0 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.0 | 0.1 | GO:1904353 | regulation of telomere capping(GO:1904353) |
0.0 | 0.7 | GO:1903749 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) |
0.0 | 0.0 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.0 | 0.0 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.0 | 0.1 | GO:0033146 | regulation of intracellular estrogen receptor signaling pathway(GO:0033146) |
0.0 | 0.0 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.0 | 0.0 | GO:0019471 | 4-hydroxyproline metabolic process(GO:0019471) |
0.0 | 0.0 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
0.0 | 0.2 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.0 | 0.0 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
0.0 | 0.1 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.0 | 0.0 | GO:0007141 | male meiosis I(GO:0007141) |
0.0 | 0.0 | GO:0061515 | myeloid cell development(GO:0061515) |
0.0 | 0.1 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.0 | 0.0 | GO:1902116 | negative regulation of organelle assembly(GO:1902116) |
0.0 | 0.0 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.0 | 0.0 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.0 | 0.0 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.0 | 0.0 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.0 | 0.0 | GO:0042976 | activation of Janus kinase activity(GO:0042976) |
0.0 | 0.0 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.0 | 0.0 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.0 | 0.0 | GO:0050701 | interleukin-1 secretion(GO:0050701) |
0.0 | 0.1 | GO:0050000 | chromosome localization(GO:0050000) |
0.0 | 0.0 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.0 | 0.0 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 0.0 | GO:0014009 | glial cell proliferation(GO:0014009) |
0.0 | 0.0 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) |
0.0 | 0.0 | GO:0033700 | phospholipid efflux(GO:0033700) |
0.0 | 0.0 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.0 | 0.0 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.0 | 0.0 | GO:0030421 | defecation(GO:0030421) |
0.0 | 0.0 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.0 | 0.0 | GO:0051944 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.0 | 0.0 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.0 | 0.0 | GO:0045910 | negative regulation of DNA recombination(GO:0045910) |
0.0 | 0.0 | GO:0001974 | blood vessel remodeling(GO:0001974) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.3 | 7.0 | GO:0005594 | collagen type IX trimer(GO:0005594) |
2.1 | 2.1 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
2.0 | 10.2 | GO:0071438 | invadopodium membrane(GO:0071438) |
1.0 | 12.2 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
1.0 | 10.1 | GO:0001527 | microfibril(GO:0001527) |
1.0 | 3.8 | GO:0071953 | elastic fiber(GO:0071953) |
0.8 | 2.4 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.8 | 4.6 | GO:0031983 | vesicle lumen(GO:0031983) |
0.7 | 2.9 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.7 | 2.2 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.6 | 5.7 | GO:0097542 | ciliary tip(GO:0097542) |
0.6 | 1.2 | GO:0016460 | myosin II complex(GO:0016460) |
0.6 | 2.3 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.6 | 1.7 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.6 | 3.3 | GO:0042629 | mast cell granule(GO:0042629) |
0.5 | 4.4 | GO:0005861 | troponin complex(GO:0005861) |
0.5 | 1.6 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.5 | 2.0 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.5 | 1.8 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.4 | 2.8 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.4 | 1.2 | GO:1990393 | 3M complex(GO:1990393) |
0.4 | 2.0 | GO:0008091 | spectrin(GO:0008091) |
0.4 | 4.7 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.4 | 0.8 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.4 | 1.6 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.4 | 2.3 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.4 | 1.9 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.4 | 25.1 | GO:0005581 | collagen trimer(GO:0005581) |
0.4 | 3.0 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.4 | 4.5 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.4 | 0.7 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.4 | 2.1 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.4 | 2.1 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.3 | 1.0 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.3 | 0.7 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.3 | 1.0 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.3 | 0.7 | GO:0005914 | spot adherens junction(GO:0005914) |
0.3 | 1.2 | GO:0030056 | hemidesmosome(GO:0030056) |
0.3 | 19.3 | GO:0032432 | actin filament bundle(GO:0032432) |
0.3 | 0.6 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.3 | 1.4 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.3 | 2.7 | GO:0031143 | pseudopodium(GO:0031143) |
0.3 | 1.6 | GO:0000812 | Swr1 complex(GO:0000812) |
0.3 | 11.0 | GO:0045095 | keratin filament(GO:0045095) |
0.3 | 1.3 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.3 | 0.8 | GO:0097443 | sorting endosome(GO:0097443) |
0.3 | 4.1 | GO:0043218 | compact myelin(GO:0043218) |
0.3 | 0.8 | GO:1990357 | terminal web(GO:1990357) |
0.3 | 1.0 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.2 | 3.0 | GO:0005652 | nuclear lamina(GO:0005652) |
0.2 | 1.2 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.2 | 1.7 | GO:0005688 | U6 snRNP(GO:0005688) |
0.2 | 0.5 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.2 | 1.2 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.2 | 74.7 | GO:0031012 | extracellular matrix(GO:0031012) |
0.2 | 4.6 | GO:0042588 | zymogen granule(GO:0042588) |
0.2 | 78.2 | GO:0005667 | transcription factor complex(GO:0005667) |
0.2 | 0.9 | GO:1990745 | EARP complex(GO:1990745) |
0.2 | 2.0 | GO:0060091 | kinocilium(GO:0060091) |
0.2 | 0.6 | GO:1990696 | USH2 complex(GO:1990696) |
0.2 | 0.2 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.2 | 3.0 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.2 | 3.5 | GO:0030057 | desmosome(GO:0030057) |
0.2 | 0.4 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.2 | 55.1 | GO:0005925 | focal adhesion(GO:0005925) |
0.2 | 1.2 | GO:0031209 | SCAR complex(GO:0031209) |
0.2 | 1.1 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.2 | 3.1 | GO:0010369 | chromocenter(GO:0010369) |
0.2 | 0.8 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.2 | 2.1 | GO:0044453 | nuclear membrane part(GO:0044453) |
0.2 | 3.1 | GO:0045120 | pronucleus(GO:0045120) |
0.2 | 0.4 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.2 | 0.4 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.2 | 0.5 | GO:1990423 | RZZ complex(GO:1990423) |
0.2 | 0.5 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.2 | 0.9 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.2 | 1.6 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 0.7 | GO:0070545 | PeBoW complex(GO:0070545) |
0.2 | 1.9 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.2 | 1.8 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.2 | 10.3 | GO:0005902 | microvillus(GO:0005902) |
0.2 | 0.6 | GO:0042382 | paraspeckles(GO:0042382) |
0.2 | 0.3 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.2 | 0.9 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.2 | 0.3 | GO:0000322 | storage vacuole(GO:0000322) |
0.2 | 0.5 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.2 | 0.5 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.2 | 1.2 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.4 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 0.9 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.6 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.1 | 1.4 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 0.3 | GO:0044462 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.1 | 0.6 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.1 | 3.4 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 1.1 | GO:0070938 | contractile ring(GO:0070938) |
0.1 | 2.6 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 1.2 | GO:0036128 | CatSper complex(GO:0036128) |
0.1 | 0.1 | GO:0030891 | VCB complex(GO:0030891) |
0.1 | 0.5 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.1 | 1.7 | GO:0038201 | TOR complex(GO:0038201) |
0.1 | 2.9 | GO:0000791 | euchromatin(GO:0000791) |
0.1 | 0.4 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.1 | 0.8 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 2.6 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 0.5 | GO:0032806 | carboxy-terminal domain protein kinase complex(GO:0032806) |
0.1 | 1.1 | GO:0036156 | inner dynein arm(GO:0036156) |
0.1 | 0.4 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.1 | 0.2 | GO:1990635 | proximal dendrite(GO:1990635) |
0.1 | 0.4 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 1.4 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 0.4 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.1 | 0.2 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.1 | 0.5 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 0.8 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 0.3 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.1 | 3.6 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.6 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.1 | 0.3 | GO:0016939 | kinesin II complex(GO:0016939) |
0.1 | 1.2 | GO:0031430 | M band(GO:0031430) |
0.1 | 0.4 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.1 | 0.1 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.1 | 1.0 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 0.3 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 1.3 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 0.4 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 0.4 | GO:0001739 | sex chromatin(GO:0001739) |
0.1 | 4.1 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 0.3 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.1 | 1.1 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 0.5 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 0.8 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.1 | 5.6 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.3 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 1.4 | GO:0031672 | A band(GO:0031672) |
0.1 | 1.4 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 0.4 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 0.9 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.7 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 4.6 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 0.6 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 0.1 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.1 | 1.0 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.1 | 0.7 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 0.4 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.1 | 0.2 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.1 | 7.6 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 1.8 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 0.6 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 0.4 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 0.8 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 1.0 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.1 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.1 | 0.4 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 1.8 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 0.3 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.1 | 0.3 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.1 | 0.4 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.1 | 4.1 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 4.0 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.3 | GO:0072487 | MSL complex(GO:0072487) |
0.1 | 1.0 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 0.7 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 0.1 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.1 | 0.1 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 0.2 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 1.2 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 1.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.2 | GO:0043511 | inhibin complex(GO:0043511) |
0.1 | 0.6 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 0.9 | GO:0008305 | integrin complex(GO:0008305) |
0.1 | 0.8 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.2 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 0.3 | GO:1990246 | uniplex complex(GO:1990246) |
0.1 | 0.2 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.1 | 0.2 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 0.4 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.1 | 1.0 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 0.2 | GO:0098536 | deuterosome(GO:0098536) |
0.1 | 0.3 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.1 | 0.4 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.1 | 0.1 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.1 | 0.4 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 0.2 | GO:0000802 | transverse filament(GO:0000802) |
0.1 | 0.5 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.1 | 0.3 | GO:0005683 | U7 snRNP(GO:0005683) |
0.1 | 0.9 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 0.1 | GO:0033202 | DNA helicase complex(GO:0033202) |
0.1 | 0.2 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.1 | 0.4 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.1 | 0.1 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.1 | 7.8 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.1 | 0.3 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 0.3 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.1 | 4.3 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.1 | 0.3 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 0.3 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 1.0 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.1 | 0.2 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.1 | 0.1 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.1 | 1.1 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.1 | 0.5 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 0.9 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.2 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 4.0 | GO:0005903 | brush border(GO:0005903) |
0.1 | 0.1 | GO:0031523 | Myb complex(GO:0031523) |
0.1 | 0.5 | GO:0043073 | germ cell nucleus(GO:0043073) |
0.1 | 0.2 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.1 | 0.8 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 1.0 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 0.2 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 0.7 | GO:0030686 | 90S preribosome(GO:0030686) |
0.1 | 0.2 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.1 | 0.2 | GO:0001652 | granular component(GO:0001652) |
0.1 | 0.3 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.1 | 0.2 | GO:0035838 | growing cell tip(GO:0035838) |
0.1 | 1.8 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 0.5 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.5 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 0.3 | GO:0043657 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.0 | 0.4 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 47.4 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 1.7 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.4 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.0 | 0.4 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.1 | GO:0097342 | ripoptosome(GO:0097342) |
0.0 | 0.2 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 0.3 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 0.2 | GO:0090543 | Flemming body(GO:0090543) |
0.0 | 0.2 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 0.4 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.0 | 1.8 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 0.3 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 0.3 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 0.2 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.0 | 0.5 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 0.8 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.0 | 0.1 | GO:0032994 | protein-lipid complex(GO:0032994) |
0.0 | 0.0 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.0 | 0.7 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 0.2 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.0 | 0.2 | GO:0042641 | actomyosin(GO:0042641) |
0.0 | 0.1 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.0 | 1.6 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.2 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.0 | 0.9 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 0.1 | GO:0071564 | npBAF complex(GO:0071564) |
0.0 | 0.8 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.5 | GO:0051233 | spindle midzone(GO:0051233) |
0.0 | 0.8 | GO:0072686 | mitotic spindle(GO:0072686) |
0.0 | 1.0 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.4 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 0.4 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 1.2 | GO:0044438 | microbody part(GO:0044438) peroxisomal part(GO:0044439) |
0.0 | 0.3 | GO:0044452 | nucleolar part(GO:0044452) |
0.0 | 0.2 | GO:0070652 | HAUS complex(GO:0070652) |
0.0 | 0.1 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 0.1 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) |
0.0 | 0.1 | GO:0035339 | SPOTS complex(GO:0035339) |
0.0 | 0.1 | GO:0072687 | meiotic spindle(GO:0072687) |
0.0 | 0.0 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.0 | 0.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.6 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.3 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.2 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.0 | 0.1 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 0.1 | GO:0042825 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.0 | 0.2 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 0.1 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.0 | 0.1 | GO:0000243 | commitment complex(GO:0000243) |
0.0 | 0.1 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.0 | 0.3 | GO:0032797 | SMN complex(GO:0032797) |
0.0 | 1.6 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 2.2 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.0 | 0.0 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.0 | 0.1 | GO:0044299 | C-fiber(GO:0044299) |
0.0 | 0.1 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.0 | 0.1 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.0 | 0.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.0 | 0.3 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.0 | 0.1 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.0 | 1.3 | GO:0005814 | centriole(GO:0005814) |
0.0 | 1.5 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.2 | GO:0005685 | U1 snRNP(GO:0005685) |
0.0 | 0.4 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.0 | 0.2 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.0 | 0.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.0 | 0.1 | GO:0071797 | LUBAC complex(GO:0071797) |
0.0 | 2.2 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.1 | GO:0002177 | manchette(GO:0002177) |
0.0 | 0.1 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.0 | 0.2 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
0.0 | 0.0 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
0.0 | 0.1 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 0.0 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.0 | 0.1 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.0 | 0.0 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.0 | 0.0 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.0 | 0.0 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 0.0 | GO:1990923 | PET complex(GO:1990923) |
0.0 | 0.0 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 0.1 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.0 | 0.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.1 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 9.4 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
1.8 | 14.4 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
1.7 | 8.7 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
1.3 | 6.7 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
1.3 | 3.8 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
1.2 | 4.9 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
1.2 | 3.5 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
1.2 | 11.7 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
1.1 | 7.4 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
1.1 | 3.2 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
1.0 | 10.2 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
1.0 | 9.0 | GO:0038191 | neuropilin binding(GO:0038191) |
1.0 | 5.9 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
1.0 | 3.8 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.9 | 2.8 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.9 | 2.8 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.9 | 3.8 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.9 | 1.7 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.8 | 2.5 | GO:0016015 | morphogen activity(GO:0016015) |
0.8 | 2.4 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.8 | 3.2 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.8 | 4.6 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.8 | 4.6 | GO:0030274 | LIM domain binding(GO:0030274) |
0.7 | 3.0 | GO:0009374 | biotin binding(GO:0009374) |
0.7 | 2.9 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.7 | 2.2 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.7 | 2.8 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.7 | 8.1 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.7 | 4.0 | GO:0034902 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.7 | 2.0 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.7 | 1.3 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.6 | 5.8 | GO:0039706 | co-receptor binding(GO:0039706) |
0.6 | 1.3 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.6 | 2.5 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.6 | 1.2 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.6 | 3.6 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.6 | 1.8 | GO:0030984 | kininogen binding(GO:0030984) |
0.6 | 2.3 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.6 | 2.3 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.6 | 1.7 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.6 | 2.3 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.6 | 2.2 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.5 | 2.5 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.5 | 12.3 | GO:0001968 | fibronectin binding(GO:0001968) |
0.5 | 2.0 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.5 | 1.5 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.5 | 2.4 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.5 | 1.9 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.5 | 3.8 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.5 | 1.4 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.5 | 5.6 | GO:0043394 | proteoglycan binding(GO:0043394) heparan sulfate proteoglycan binding(GO:0043395) |
0.5 | 10.5 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.5 | 17.6 | GO:0005518 | collagen binding(GO:0005518) |
0.4 | 3.6 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.4 | 1.3 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.4 | 1.7 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.4 | 2.1 | GO:1990254 | keratin filament binding(GO:1990254) |
0.4 | 0.4 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.4 | 2.9 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.4 | 4.1 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.4 | 1.2 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.4 | 2.0 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.4 | 27.4 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.4 | 1.2 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.4 | 1.6 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.4 | 0.8 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.4 | 1.5 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.4 | 7.5 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.4 | 0.8 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.4 | 2.6 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.4 | 1.1 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.4 | 1.8 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.3 | 1.4 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.3 | 1.4 | GO:0031014 | troponin T binding(GO:0031014) |
0.3 | 6.5 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.3 | 4.8 | GO:0005521 | lamin binding(GO:0005521) |
0.3 | 2.0 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.3 | 2.4 | GO:0046790 | virion binding(GO:0046790) |
0.3 | 0.7 | GO:0015205 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.3 | 1.7 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.3 | 0.3 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.3 | 1.0 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.3 | 1.0 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.3 | 1.7 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.3 | 3.6 | GO:0017166 | vinculin binding(GO:0017166) |
0.3 | 6.6 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.3 | 0.7 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.3 | 0.3 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.3 | 1.0 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.3 | 8.2 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.3 | 3.7 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.3 | 0.6 | GO:0030172 | troponin C binding(GO:0030172) |
0.3 | 7.8 | GO:0005109 | frizzled binding(GO:0005109) |
0.3 | 0.9 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.3 | 0.9 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.3 | 2.0 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.3 | 4.4 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.3 | 0.9 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.3 | 1.2 | GO:0038100 | nodal binding(GO:0038100) |
0.3 | 8.3 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.3 | 0.9 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.3 | 0.8 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.3 | 1.7 | GO:0050700 | CARD domain binding(GO:0050700) |
0.3 | 1.4 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.3 | 0.8 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.3 | 4.8 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.3 | 1.6 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.3 | 0.8 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.3 | 4.5 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.3 | 1.1 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.3 | 1.6 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.3 | 0.8 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.3 | 4.6 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.3 | 8.2 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.3 | 0.8 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.3 | 0.5 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.3 | 0.3 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.2 | 0.7 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.2 | 1.0 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.2 | 0.7 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.2 | 0.7 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.2 | 1.4 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.2 | 0.7 | GO:0005534 | galactose binding(GO:0005534) |
0.2 | 0.9 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.2 | 0.7 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.2 | 0.5 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.2 | 1.6 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.2 | 2.1 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.2 | 1.2 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.2 | 21.5 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.2 | 0.5 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.2 | 4.3 | GO:0031489 | myosin V binding(GO:0031489) |
0.2 | 0.2 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.2 | 1.3 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.2 | 0.9 | GO:0045340 | mercury ion binding(GO:0045340) |
0.2 | 0.2 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.2 | 0.7 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.2 | 1.1 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.2 | 0.7 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.2 | 0.2 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.2 | 0.4 | GO:0035939 | microsatellite binding(GO:0035939) |
0.2 | 0.9 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.2 | 1.1 | GO:0035671 | enone reductase activity(GO:0035671) |
0.2 | 0.7 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.2 | 6.9 | GO:0070888 | E-box binding(GO:0070888) |
0.2 | 0.6 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
0.2 | 20.2 | GO:0008201 | heparin binding(GO:0008201) |
0.2 | 0.2 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.2 | 0.6 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.2 | 0.8 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.2 | 0.6 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.2 | 0.6 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.2 | 0.2 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.2 | 0.8 | GO:0052794 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.2 | 0.2 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.2 | 0.6 | GO:0015154 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.2 | 2.8 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.2 | 1.8 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.2 | 0.4 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.2 | 3.0 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.2 | 2.2 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.2 | 2.2 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.2 | 0.8 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.2 | 0.6 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.2 | 2.8 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 1.8 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.2 | 7.7 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.2 | 1.0 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.2 | 0.4 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.2 | 0.4 | GO:0043199 | sulfate binding(GO:0043199) |
0.2 | 0.4 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.2 | 1.2 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.2 | 0.2 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.2 | 0.6 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.2 | 0.4 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.2 | 1.1 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.2 | 0.4 | GO:0004096 | catalase activity(GO:0004096) |
0.2 | 1.5 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.2 | 1.7 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.2 | 16.7 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.2 | 0.7 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.2 | 1.5 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.2 | 0.5 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.2 | 1.6 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.2 | 0.5 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.2 | 1.8 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.2 | 0.9 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.2 | 1.6 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.2 | 0.7 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.2 | 0.7 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.2 | 0.7 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.2 | 0.9 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.2 | 0.5 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.2 | 0.2 | GO:0036222 | XTP diphosphatase activity(GO:0036222) |
0.2 | 0.7 | GO:0043912 | D-lysine oxidase activity(GO:0043912) |
0.2 | 0.2 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.2 | 2.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.2 | 2.2 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.2 | 0.7 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.2 | 0.8 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.2 | 0.2 | GO:0051870 | methotrexate binding(GO:0051870) |
0.2 | 2.9 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.2 | 1.6 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.2 | 5.4 | GO:0017022 | myosin binding(GO:0017022) |
0.2 | 1.1 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.2 | 0.5 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.2 | 8.0 | GO:0005178 | integrin binding(GO:0005178) |
0.2 | 0.5 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.2 | 0.8 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.2 | 1.1 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.2 | 0.9 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.2 | 1.5 | GO:0031996 | thioesterase binding(GO:0031996) |
0.2 | 0.5 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.2 | 5.5 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.2 | 0.6 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.2 | 0.5 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.2 | 0.6 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 2.8 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 1.0 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 0.3 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 1.8 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.6 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
0.1 | 0.3 | GO:0016531 | copper chaperone activity(GO:0016531) |
0.1 | 0.4 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.1 | 0.6 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 0.3 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.1 | 0.6 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.1 | 1.7 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.6 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.1 | 0.6 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 1.3 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.1 | 0.4 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 0.4 | GO:0034618 | arginine binding(GO:0034618) |
0.1 | 0.4 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.1 | 0.1 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.1 | 2.2 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.4 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.1 | 0.5 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 1.2 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.1 | 1.2 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.1 | 0.4 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.1 | 0.5 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.1 | 0.4 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.1 | 1.1 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.1 | 0.3 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.1 | 1.4 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.4 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.1 | 0.4 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.1 | 6.2 | GO:0019838 | growth factor binding(GO:0019838) |
0.1 | 1.3 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.4 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.1 | 0.3 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 0.4 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.8 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.1 | 1.4 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.1 | 0.6 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.1 | 0.1 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.1 | 1.0 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.1 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.1 | 0.7 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 0.2 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.1 | 0.1 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.1 | 0.6 | GO:0016936 | galactoside binding(GO:0016936) |
0.1 | 0.4 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.1 | 0.5 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.7 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.1 | 0.9 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.1 | 0.7 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.1 | 0.1 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
0.1 | 1.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 1.3 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 0.8 | GO:0018657 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.1 | 0.3 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.1 | 0.4 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 0.4 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
0.1 | 0.2 | GO:0035877 | death effector domain binding(GO:0035877) |
0.1 | 0.2 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.1 | 0.5 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 0.3 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.1 | 0.3 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 0.9 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.1 | 1.0 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 0.6 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.2 | GO:2001070 | starch binding(GO:2001070) |
0.1 | 0.4 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.2 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 1.7 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.1 | 1.7 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 0.1 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.1 | 0.4 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.4 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 0.3 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 0.5 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.1 | 0.5 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.1 | 1.8 | GO:0017069 | snRNA binding(GO:0017069) |
0.1 | 0.6 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.1 | 0.4 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.1 | 0.4 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.3 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.1 | 0.4 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.1 | 0.2 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.1 | 0.4 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 0.9 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 0.4 | GO:0034916 | 4-methyloctanoyl-CoA dehydrogenase activity(GO:0034580) naphthyl-2-methyl-succinyl-CoA dehydrogenase activity(GO:0034845) 2-methylhexanoyl-CoA dehydrogenase activity(GO:0034916) propionyl-CoA dehydrogenase activity(GO:0043820) thiol-driven fumarate reductase activity(GO:0043830) coenzyme F420-dependent 2,4,6-trinitrophenol reductase activity(GO:0052758) coenzyme F420-dependent 2,4,6-trinitrophenol hydride reductase activity(GO:0052759) coenzyme F420-dependent 2,4-dinitrophenol reductase activity(GO:0052760) |
0.1 | 0.3 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.1 | 0.4 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.3 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 1.4 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.3 | GO:0001030 | RNA polymerase III regulatory region DNA binding(GO:0001016) RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.1 | 2.2 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.1 | 0.1 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.1 | 0.4 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 1.0 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 0.1 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.1 | 0.3 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 0.3 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 0.2 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.1 | 0.4 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.1 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 0.4 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 8.0 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 0.9 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.1 | 0.4 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.1 | 0.1 | GO:0044213 | intronic transcription regulatory region DNA binding(GO:0044213) |
0.1 | 0.4 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.1 | 1.0 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.4 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.1 | 0.2 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.1 | 0.2 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.1 | 0.2 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.1 | 0.9 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 0.4 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.1 | 0.1 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 0.8 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.4 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 0.3 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 0.9 | GO:0044466 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.1 | 0.3 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 0.4 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.1 | 0.4 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 0.3 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 7.2 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.1 | 0.2 | GO:0035173 | histone kinase activity(GO:0035173) |
0.1 | 0.9 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 0.2 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 0.3 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.1 | 0.6 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 2.3 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 0.3 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.1 | 0.2 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.1 | 0.2 | GO:0051425 | PTB domain binding(GO:0051425) |
0.1 | 2.3 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 0.6 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 0.2 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.7 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 0.2 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.1 | 0.5 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 0.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.9 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 0.2 | GO:0030519 | snoRNP binding(GO:0030519) |
0.1 | 1.6 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.1 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.1 | 0.8 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.1 | 1.7 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.2 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.1 | 0.2 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 0.2 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 0.4 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.1 | 0.2 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.1 | 0.3 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.1 | 0.3 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.1 | 0.5 | GO:0000150 | recombinase activity(GO:0000150) |
0.1 | 0.4 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 0.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 0.2 | GO:0060229 | phospholipase activator activity(GO:0016004) lipase activator activity(GO:0060229) |
0.1 | 0.2 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.1 | 0.2 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 0.2 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 0.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.9 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.1 | 0.6 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 0.2 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.1 | 1.2 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 1.2 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 0.6 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.1 | 0.3 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 0.2 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.1 | 0.5 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.1 | 0.1 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.1 | 0.1 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.1 | 0.1 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.1 | 2.0 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 0.5 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.1 | 0.5 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.1 | 0.6 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.1 | 0.1 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.1 | 0.1 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.1 | 2.1 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 0.3 | GO:1990446 | snRNP binding(GO:0070990) U1 snRNP binding(GO:1990446) |
0.1 | 0.1 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
0.1 | 0.1 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) |
0.1 | 0.1 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.1 | 0.4 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 0.2 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 0.4 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.8 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.1 | 0.4 | GO:0008469 | histone-arginine N-methyltransferase activity(GO:0008469) |
0.1 | 0.1 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.1 | 0.2 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.1 | 0.2 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.1 | 0.2 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.1 | 0.8 | GO:0015116 | secondary active sulfate transmembrane transporter activity(GO:0008271) sulfate transmembrane transporter activity(GO:0015116) |
0.1 | 0.4 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 2.1 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 0.7 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.1 | 0.7 | GO:0090484 | drug transporter activity(GO:0090484) |
0.1 | 1.1 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.2 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.3 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.1 | 0.5 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 0.1 | GO:0089720 | caspase binding(GO:0089720) |
0.1 | 0.7 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.8 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 1.2 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.1 | 0.1 | GO:0004083 | bisphosphoglycerate 2-phosphatase activity(GO:0004083) |
0.1 | 0.4 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 0.1 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.1 | 0.3 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.2 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.1 | 17.6 | GO:0003682 | chromatin binding(GO:0003682) |
0.1 | 0.4 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 0.1 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.1 | 0.1 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.1 | 0.2 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 0.3 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 0.1 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.1 | 0.6 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 0.2 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.1 | 0.2 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 0.3 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 0.2 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.1 | 0.2 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.1 | 0.1 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.0 | 2.0 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.1 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.2 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.2 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.0 | 0.3 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.0 | 0.3 | GO:0008199 | ferric iron binding(GO:0008199) |
0.0 | 1.1 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.0 | 0.2 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.0 | 0.2 | GO:0004031 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.0 | 0.3 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.0 | 0.3 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 0.0 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
0.0 | 2.8 | GO:0008026 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.0 | 0.2 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.0 | 0.6 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.0 | 0.2 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.0 | 0.5 | GO:0043864 | protein-N-terminal asparagine amidohydrolase activity(GO:0008418) UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase activity(GO:0008759) iprodione amidohydrolase activity(GO:0018748) (3,5-dichlorophenylurea)acetate amidohydrolase activity(GO:0018749) 4'-(2-hydroxyisopropyl)phenylurea amidohydrolase activity(GO:0034571) didemethylisoproturon amidohydrolase activity(GO:0034573) N-isopropylacetanilide amidohydrolase activity(GO:0034576) N-cyclohexylformamide amidohydrolase activity(GO:0034781) isonicotinic acid hydrazide hydrolase activity(GO:0034876) cis-aconitamide amidase activity(GO:0034882) gamma-N-formylaminovinylacetate hydrolase activity(GO:0034885) N2-acetyl-L-lysine deacetylase activity(GO:0043747) O-succinylbenzoate synthase activity(GO:0043748) indoleacetamide hydrolase activity(GO:0043864) N-acetylcitrulline deacetylase activity(GO:0043909) N-acetylgalactosamine-6-phosphate deacetylase activity(GO:0047419) diacetylchitobiose deacetylase activity(GO:0052773) chitooligosaccharide deacetylase activity(GO:0052790) |
0.0 | 0.4 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.0 | 0.0 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.0 | 0.2 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 0.8 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.2 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.2 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.0 | 1.4 | GO:0000049 | tRNA binding(GO:0000049) |
0.0 | 7.0 | GO:0061659 | ubiquitin-like protein ligase activity(GO:0061659) |
0.0 | 0.0 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.0 | 0.2 | GO:0048038 | quinone binding(GO:0048038) |
0.0 | 0.1 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.0 | 0.2 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.2 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.0 | 0.6 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.4 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.1 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.0 | 0.1 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.0 | 0.1 | GO:0015232 | heme transporter activity(GO:0015232) |
0.0 | 0.4 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.4 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.0 | 0.5 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 6.9 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.1 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.0 | 0.5 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.2 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.0 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.0 | 0.1 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.0 | 0.3 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.0 | 0.1 | GO:0005165 | neurotrophin receptor binding(GO:0005165) |
0.0 | 0.0 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.0 | 0.0 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.0 | 0.8 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.3 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.0 | 0.1 | GO:0019002 | GMP binding(GO:0019002) |
0.0 | 0.1 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.0 | 0.0 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.0 | 0.1 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.0 | 0.1 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.0 | 0.0 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.0 | 0.0 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.0 | 0.5 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 1.5 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 0.1 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.0 | 0.1 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.0 | 0.7 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 1.0 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.1 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.0 | 0.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.0 | 0.1 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.0 | 0.0 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.0 | 0.1 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.0 | 0.0 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.0 | 0.1 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.0 | 0.0 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.0 | 0.0 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.1 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.0 | 0.2 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 1.8 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.0 | 0.1 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.0 | 0.1 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.0 | 0.0 | GO:0071253 | connexin binding(GO:0071253) |
0.0 | 0.3 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.0 | 0.1 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.0 | 0.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.3 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.2 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 2.7 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.0 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.0 | 3.6 | GO:0008134 | transcription factor binding(GO:0008134) |
0.0 | 0.1 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.0 | 0.1 | GO:0034956 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.0 | 0.1 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.0 | 0.7 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.1 | GO:0043566 | structure-specific DNA binding(GO:0043566) |
0.0 | 0.0 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.0 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
0.0 | 0.1 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.0 | 0.1 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.0 | GO:0004953 | icosanoid receptor activity(GO:0004953) |
0.0 | 0.1 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.0 | 0.1 | GO:0001846 | opsonin binding(GO:0001846) |
0.0 | 0.5 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.0 | 5.8 | GO:0003779 | actin binding(GO:0003779) |
0.0 | 0.7 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.0 | 0.0 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.0 | 0.8 | GO:0001047 | core promoter binding(GO:0001047) |
0.0 | 0.0 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.0 | GO:0005113 | patched binding(GO:0005113) |
0.0 | 0.2 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 1.7 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.0 | 0.1 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.0 | 0.1 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.0 | 0.1 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.0 | 0.7 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.6 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.0 | 0.0 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.0 | 0.2 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 2.3 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 0.0 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.0 | 0.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.0 | 0.0 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.0 | 2.6 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.0 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.0 | 0.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.3 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.0 | 0.1 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.0 | 0.1 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.0 | 0.1 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.0 | 0.0 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.0 | 0.3 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.0 | 0.3 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.0 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.0 | 0.1 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.0 | 0.0 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
0.0 | 0.0 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.0 | 0.0 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.0 | 0.0 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.0 | 0.0 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.0 | 0.0 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.0 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.0 | 0.1 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
0.0 | 0.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.3 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.0 | 0.0 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.0 | 0.0 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 32.9 | NABA COLLAGENS | Genes encoding collagen proteins |
0.7 | 0.7 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.7 | 18.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.5 | 16.0 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.5 | 20.3 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.4 | 10.6 | PID ALK1 PATHWAY | ALK1 signaling events |
0.4 | 9.7 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.4 | 2.7 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.4 | 0.4 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.4 | 6.7 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.4 | 4.0 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.4 | 15.9 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.3 | 13.9 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.3 | 6.4 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.3 | 11.1 | PID BMP PATHWAY | BMP receptor signaling |
0.3 | 3.0 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.3 | 5.5 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.3 | 3.6 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.3 | 0.3 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.3 | 2.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.3 | 41.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.3 | 7.9 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.3 | 5.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.3 | 3.6 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.3 | 4.1 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.2 | 4.6 | PID ENDOTHELIN PATHWAY | Endothelins |
0.2 | 4.1 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.2 | 2.9 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.2 | 0.7 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.2 | 0.7 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 3.6 | ST GAQ PATHWAY | G alpha q Pathway |
0.2 | 1.1 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.2 | 6.1 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.2 | 1.9 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.2 | 1.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 0.4 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.2 | 3.9 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.2 | 3.6 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.2 | 2.2 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.2 | 5.0 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.2 | 7.6 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.2 | 5.2 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.2 | 2.2 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.2 | 10.5 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.2 | 2.4 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.2 | 3.1 | PID ARF6 PATHWAY | Arf6 signaling events |
0.2 | 0.9 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.2 | 1.3 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.2 | 1.7 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.2 | 32.2 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.2 | 5.9 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.2 | 1.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.2 | 3.1 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.2 | 3.8 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.2 | 3.8 | PID BARD1 PATHWAY | BARD1 signaling events |
0.2 | 2.1 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.2 | 1.7 | PID AURORA A PATHWAY | Aurora A signaling |
0.2 | 3.5 | PID FGF PATHWAY | FGF signaling pathway |
0.2 | 1.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.2 | 0.3 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 0.1 | ST STAT3 PATHWAY | STAT3 Pathway |
0.1 | 0.4 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 1.3 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 0.9 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 1.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 0.3 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 1.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 30.9 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 0.3 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 2.4 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 4.6 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 15.2 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.1 | 3.0 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 1.0 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 0.5 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 0.5 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 1.3 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 2.2 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 0.2 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 0.1 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 0.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 2.7 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 0.1 | PID EPO PATHWAY | EPO signaling pathway |
0.1 | 4.6 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 1.1 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 0.6 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 2.7 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 2.5 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 1.5 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 2.6 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 1.1 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 1.0 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 1.1 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 1.7 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 0.6 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 0.1 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.1 | 0.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 1.0 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 0.3 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 0.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 1.9 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 1.4 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 0.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 0.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 0.5 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 0.4 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 0.3 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 0.3 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 0.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 0.9 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 0.4 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 0.9 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 0.2 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 2.2 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.3 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.6 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.2 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.0 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 0.1 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 1.1 | NABA MATRISOME | Ensemble of genes encoding extracellular matrix and extracellular matrix-associated proteins |
0.0 | 0.2 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.2 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.0 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.2 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.0 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.0 | 0.4 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.3 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.1 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.3 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.2 | PID P73PATHWAY | p73 transcription factor network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 22.0 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
1.5 | 1.5 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.7 | 37.6 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.7 | 11.2 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.5 | 11.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.4 | 5.4 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.4 | 4.1 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.4 | 4.5 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.4 | 3.0 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.4 | 4.6 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.3 | 5.1 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.3 | 3.5 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.3 | 0.6 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
0.3 | 2.1 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.3 | 6.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.3 | 2.3 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.3 | 0.8 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.3 | 3.0 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.3 | 3.1 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.2 | 1.9 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.2 | 5.3 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.2 | 2.2 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.2 | 2.7 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.2 | 1.8 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 2.1 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.2 | 3.5 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.2 | 1.0 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.2 | 4.0 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.2 | 2.4 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.2 | 2.0 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.2 | 2.2 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.2 | 2.8 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.2 | 1.8 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 0.2 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.2 | 2.1 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 0.6 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.2 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.2 | 3.2 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.2 | 1.4 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.2 | 18.3 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.2 | 4.9 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.2 | 3.8 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.2 | 1.0 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.2 | 1.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.2 | 0.6 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.2 | 0.3 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.2 | 1.3 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.2 | 1.4 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.2 | 6.6 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.2 | 1.2 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 1.7 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.1 | 2.0 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 1.4 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 1.2 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 1.5 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 2.2 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 0.1 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 0.3 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.1 | 2.0 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 1.3 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 1.3 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 1.5 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 5.5 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 1.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 3.4 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 1.4 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 1.5 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 0.2 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.1 | 0.1 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.1 | 0.7 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 1.8 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 9.9 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 0.1 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 1.2 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 1.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.1 | 1.5 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 0.7 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 0.3 | REACTOME GLYCOSAMINOGLYCAN METABOLISM | Genes involved in Glycosaminoglycan metabolism |
0.1 | 0.2 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.1 | 4.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 2.3 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.1 | 1.3 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 0.5 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 0.5 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 4.6 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.1 | 2.0 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 1.0 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.1 | 1.5 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 0.7 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 1.6 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.1 | 0.3 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.1 | 0.6 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.1 | 0.2 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 3.8 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 1.6 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 1.0 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 0.3 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 0.7 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 0.7 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 0.3 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 3.6 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 1.2 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 0.8 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.1 | 2.1 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 3.4 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 1.0 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 0.5 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.1 | 2.1 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 0.5 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 0.6 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 0.4 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.1 | 1.6 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.1 | 0.1 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
0.1 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 0.1 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.1 | 0.6 | REACTOME CHROMOSOME MAINTENANCE | Genes involved in Chromosome Maintenance |
0.1 | 1.0 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 0.5 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 2.6 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 0.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 1.0 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 2.5 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 0.4 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.1 | 1.3 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 0.5 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.1 | 1.1 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 3.1 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.1 | 0.9 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 0.6 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 0.3 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 0.1 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.1 | 0.5 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 0.6 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.1 | 3.9 | REACTOME TRANSLATION | Genes involved in Translation |
0.1 | 0.4 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 0.1 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.5 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.0 | 0.9 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.4 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.3 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 3.3 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 0.3 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.3 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.0 | 1.9 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 3.0 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.0 | 0.3 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 0.3 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 0.1 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 0.1 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.1 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 0.6 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.5 | REACTOME RNA POL II TRANSCRIPTION | Genes involved in RNA Polymerase II Transcription |
0.0 | 0.4 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.0 | 0.4 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 1.6 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 1.6 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.3 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
0.0 | 0.1 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.6 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.0 | 0.4 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.2 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 0.8 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.1 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.0 | 0.1 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.0 | 0.7 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.0 | 0.3 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.4 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.4 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.2 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.3 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.1 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.0 | 0.1 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 0.0 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 0.0 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.0 | 0.8 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.1 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 0.0 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.0 | 0.4 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 1.6 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.0 | 0.1 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.0 | 0.6 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 0.3 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.0 | 0.0 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.0 | 0.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.1 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 0.3 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.2 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.0 | 0.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.1 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |